The document provides a reference list for medical marijuana organized by condition or topic. It includes over 100 citations for studies, news articles, and anecdotes related to the use of marijuana or cannabinoids for conditions such as ADD/ADHD, alcoholism, aging/seniors, allergies, ALS, and others. The references cover a wide range of years from 1969 to 2010.
Two young men presented to the emergency room after smoking something called "voodoo". Voodoo is a synthetic cannabinoid sprayed onto herbs and sold as incense. It acts on cannabinoid receptors in the brain and body. The men experienced hallucinations, panic, and extreme fear. Synthetic cannabinoids can cause acute psychosis, seizures, heart problems, and strokes. Long term use may lead to addiction, withdrawal symptoms, and mental health issues. Treatment involves stabilizing vital signs, benzodiazepines for anxiety, and rehabilitation for addiction. Synthetic cannabinoids pose serious health risks and are illegal in Egypt.
Drug treatment is intended to help addicted individuals stop compulsive drug seeking and use. Treatment can occur in a variety of settings, take many different ...
Inside the Mind of the Marijuana User (1).pptLeonelsonCorral
This document provides an overview of marijuana, including its history, epidemiology, pharmacology, effects, and treatment. Some key points include:
- Marijuana originated in ancient China and has been used medically and socially for thousands of years.
- Current marijuana is much stronger than in the 1960s, with THC levels ranging from 4-15% compared to 1-3% previously.
- Short-term effects include relaxation, increased appetite, impaired memory and coordination. Long-term effects can include respiratory problems and cognitive impairments.
- Marijuana can impair driving ability for 3-8 hours after use and combining it with alcohol significantly worsens impairment. Drug tests can detect recent or chronic use depending on
Ameliorative effects of recombinant human erythropoietin ijrpppharmaindexing
This document discusses a study that investigated the neuroprotective effects of recombinant human erythropoietin (rhEPO) in a rat model of experimental encephalopathy induced by acrylamide. The study found that acrylamide toxicity in rats was demonstrated by increased levels of oxidative stress markers and decreased antioxidant levels in the brain. Treatment with rhEPO normalized these markers, suggesting it attenuated acrylamide-induced encephalopathy in rats. The results provide evidence that rhEPO may serve as an effective neuroprotective agent for brain disorders associated with oxidative stress.
Flower as Medicine: chrysanthemum, Chrysanthemum MorifoliumKevin KF Ng
Chrysanthemum flower, Shen Nong the Father of Chinese Medicine classified it as Superior Herb. More than 4,000 phytochemicals are known but only a few have been studied in details. Major phytochemicals are flavonoids, phenolic acids and anthocyanins. Anti-microbial, antioxidant, anti-inflammatory, immuno-modulatory, anticancer, anti-hyperglycemic and anti-hyptensive properties have been shown. Therapeutic effects have yet to be established.
Pharmacogenetics studies how a person's genetic makeup affects their response to drugs. It aims to develop personalized drug regimens to improve drug efficacy and safety. Every year in the US, adverse drug reactions cause 2 million people to experience side effects and over 100,000 die from reactions. Current drugs are only effective in 60% of the population. Pharmacogenetics uses genetic tests to determine a patient's risk of side effects or likelihood of response to a drug to help guide safer and more effective treatment decisions.
This document provides a summary of news related to pharmacotherapy for multiple sclerosis from January 2014. It includes tweets summarizing recent publications on various disease modifying therapies and symptomatic treatments, including interferons, glatiramer acetate, fingolimod, natalizumab, teriflunomide, dimethyl fumarate, daclizumab, alemtuzumab, vitamins A and D, spasticity treatments, hematopoietic transplantation, genetics, pediatrics, pregnancy, and other topics. The information is intended for healthcare professionals, and directs patients to discuss any questions with their doctor.
Two young men presented to the emergency room after smoking something called "voodoo". Voodoo is a synthetic cannabinoid sprayed onto herbs and sold as incense. It acts on cannabinoid receptors in the brain and body. The men experienced hallucinations, panic, and extreme fear. Synthetic cannabinoids can cause acute psychosis, seizures, heart problems, and strokes. Long term use may lead to addiction, withdrawal symptoms, and mental health issues. Treatment involves stabilizing vital signs, benzodiazepines for anxiety, and rehabilitation for addiction. Synthetic cannabinoids pose serious health risks and are illegal in Egypt.
Drug treatment is intended to help addicted individuals stop compulsive drug seeking and use. Treatment can occur in a variety of settings, take many different ...
Inside the Mind of the Marijuana User (1).pptLeonelsonCorral
This document provides an overview of marijuana, including its history, epidemiology, pharmacology, effects, and treatment. Some key points include:
- Marijuana originated in ancient China and has been used medically and socially for thousands of years.
- Current marijuana is much stronger than in the 1960s, with THC levels ranging from 4-15% compared to 1-3% previously.
- Short-term effects include relaxation, increased appetite, impaired memory and coordination. Long-term effects can include respiratory problems and cognitive impairments.
- Marijuana can impair driving ability for 3-8 hours after use and combining it with alcohol significantly worsens impairment. Drug tests can detect recent or chronic use depending on
Ameliorative effects of recombinant human erythropoietin ijrpppharmaindexing
This document discusses a study that investigated the neuroprotective effects of recombinant human erythropoietin (rhEPO) in a rat model of experimental encephalopathy induced by acrylamide. The study found that acrylamide toxicity in rats was demonstrated by increased levels of oxidative stress markers and decreased antioxidant levels in the brain. Treatment with rhEPO normalized these markers, suggesting it attenuated acrylamide-induced encephalopathy in rats. The results provide evidence that rhEPO may serve as an effective neuroprotective agent for brain disorders associated with oxidative stress.
Flower as Medicine: chrysanthemum, Chrysanthemum MorifoliumKevin KF Ng
Chrysanthemum flower, Shen Nong the Father of Chinese Medicine classified it as Superior Herb. More than 4,000 phytochemicals are known but only a few have been studied in details. Major phytochemicals are flavonoids, phenolic acids and anthocyanins. Anti-microbial, antioxidant, anti-inflammatory, immuno-modulatory, anticancer, anti-hyperglycemic and anti-hyptensive properties have been shown. Therapeutic effects have yet to be established.
Pharmacogenetics studies how a person's genetic makeup affects their response to drugs. It aims to develop personalized drug regimens to improve drug efficacy and safety. Every year in the US, adverse drug reactions cause 2 million people to experience side effects and over 100,000 die from reactions. Current drugs are only effective in 60% of the population. Pharmacogenetics uses genetic tests to determine a patient's risk of side effects or likelihood of response to a drug to help guide safer and more effective treatment decisions.
This document provides a summary of news related to pharmacotherapy for multiple sclerosis from January 2014. It includes tweets summarizing recent publications on various disease modifying therapies and symptomatic treatments, including interferons, glatiramer acetate, fingolimod, natalizumab, teriflunomide, dimethyl fumarate, daclizumab, alemtuzumab, vitamins A and D, spasticity treatments, hematopoietic transplantation, genetics, pediatrics, pregnancy, and other topics. The information is intended for healthcare professionals, and directs patients to discuss any questions with their doctor.
This experiment studied the effects of stress during puberty using rat models. Rats were subjected to stressful events known as juvenile social subjugation to model stress during puberty. Autoradiography was used to visualize CRF1 and CRF2 receptors in the brain which are involved in the stress response. The results found that the basolateral nucleus of the amygdala primarily expressed CRF1 receptors, while the medial preoptic nucleus secondarily expressed these receptors. The medial preoptic nucleus also expressed CRF2 receptors, but not as intensely as CRF1 receptors. Expression of both receptors increased with age and was generally higher in females compared to males. This supported the idea that females have a more plastic
This document provides information on the history, use, effects, and detection of marijuana. It begins with the origin of marijuana in Neolithic times in China or Central Asia and discusses its early uses as medicine and in social rituals. It then covers modern usage rates in the US population and among students. The document discusses the physiological and mental short-term effects of marijuana use as well as potential long-term health and mental health issues. It also outlines methods of detecting marijuana in the body and periods of detectability. Finally, it reviews diagnostic criteria for substance abuse and intoxication as defined by the DSM-IV-TR.
This document summarizes research on the neuroprotective effects of Stereospermum suaveolens DC. against Parkinson's disease and global cerebral ischemia in a rat model. Key findings include:
- S. suaveolens extract improved motor function and reduced Parkinson's disease symptoms in 6-OHDA induced rats in a dose-dependent manner based on latency, grooming, rearing, and ambulatory movement tests.
- The extract also reduced resting time in Parkinson's disease rats.
- Biochemical assays showed the extract reduced lipid peroxidation and increased antioxidant enzyme levels, suggesting it has neuroprotective effects through its antioxidant properties.
- Histopathological examination found the extract protected against
The document discusses cannabis (marijuana) and its components. It describes how cannabis originated in Central Asia and was introduced to other parts of the world. It discusses the different cannabinoids found in cannabis plants and synthesized in laboratories, including THC, CBD, and others. The document also outlines the mind and body effects of cannabis use and provides an overview of the laws and controversies around medicinal and recreational marijuana use.
[Final] Pharmacogenetics and Pharmacogenomics - WITH NOTESRaul Soto
This document summarizes a seminar presentation on the role of pharmacogenetics and pharmacogenomics in drug development and regulatory review. It discusses how genetic differences can impact how individuals metabolize and respond to drugs in terms of pharmacokinetics and pharmacodynamics. Factors like ethnicity, age, organ function, and genetics were presented as influencing a drug's effects. The role of metabolizing enzymes and transporters encoded by polymorphic genes in contributing to variability in drug responses and adverse events was emphasized. The importance of considering such genetic data during clinical trials and including relevant information in drug labels to allow for personalized dosing was also stressed.
Entactex Pharma Research Project_lap (3) (2)Lehel Simon
This document discusses research on the effects of nonapeptide agonists and antagonists on human and animal behavior. It describes how vasopressin and oxytocin receptors are located throughout the body and brain and influence various regulatory processes. The effects of agonists and antagonists that target different receptor subtypes are summarized, including their potential roles in conditions like aggression, anxiety, depression, diabetes, and social behaviors. The document also discusses genetic and epigenetic factors related to these neuropeptides and receptors.
This document summarizes a seminar presentation on the role of pharmacogenetics and pharmacogenomics in drug development and regulatory review. It discusses how genetic differences can impact how individuals metabolize and respond to drugs in terms of pharmacokinetics and pharmacodynamics. Specific polymorphisms in enzymes, receptors, and transporters were highlighted as factors that can influence a drug's effects. The importance of considering pharmacogenomic data during drug trials and regulatory reviews was emphasized in order to optimize dosing and labeling recommendations to improve drug efficacy and safety.
Classification of insecticide based on mode of action (1).pdfAsbinKatwal
Pesticides are chemicals used to control and eliminate pests that can cause damage to crops, human health, and the environment. There are various types of pesticides available in the market, and they are classified based on their mode of action, which refers to how the pesticide affects the target pest. Understanding the mode of action of pesticides is essential in choosing the right pesticide for a particular pest problem.
This document summarizes two scientific articles about recent discoveries related to gene regulation and potential new targets for treating prion diseases. The first article describes how scientists identified mystery sequences involved in gene regulation by RNA-binding proteins and the ribosome. The second reports that two compounds showed antiprion effects by binding to ribosomal RNA and inhibiting a protein, suggesting the ribosome is a new target for antiprion medicines. The document discusses the potential medical applications of further elucidating these genetic expression mechanisms.
International Journal of Clinical Pharmacology & Toxicology (IJCPT) ISSN:2167-910X is an Open Access journal, which aims to develop coherent means to modify drug therapy, with respect to the patient's genotype, and to ensure maximum efficiency with minimal contrary effects.
International Journal of Clinical Pharmacology & Toxicology (IJCPT) ISSN:2167-910X is an Open Access journal and a peer-reviewed journal. Clinical Pharmacology & Toxicology is the all-encompassing and becoming an increasingly important discipline for the identification of disease targets and drug designing with their toxicological effects and means to eradicate diseases.
Dr. Gabriel López-Berestein- Simposio Internacional 'Terapias oncológicas ava...Fundación Ramón Areces
Los días 15 y 16 de octubre de 2014, la Fundación Ramón Areces y la Real Academia Nacional de Farmacia, en colaboración con la Fundación de la Innovación Bankinter, reunieron en Madrid a algunos de los mayores expertos mundiales en nuevas terapias contra el cáncer. El Simposio Internacional, coordinado por la profesora y académica María José Alonso, analizó el momento actual de la lucha contra esta enfermedad. También fue un punto de encuentro para científicos de los más innovadores institutos de investigación en oncología, quienes debatieron sobre tres grandes temas: la Medicina Personalizada contra el cáncer, los nanomedicamentos en la terapia del cáncer y las terapias basadas en la inmunomodulación.
Maintaining adl’s in parkinson’s disease (final)dinkasfinest
The document summarizes research on the effects of an exercise intervention for patients with Parkinson's disease. It discusses an 8-subject study where participants underwent 3 one-hour exercise sessions per week for 6 months, focusing on balance, strength, technique and posture. Measures like gait, Parkinson's symptoms and quality of life were assessed before and after the intervention. The results showed improvements in these areas, suggesting exercise can help manage symptoms and quality of life for people living with Parkinson's disease.
The document summarizes a study that evaluated the psychopharmacological effects of the ethyl acetate extract of Sarcostemma acidum (EASA). Various tests were conducted to assess the anti-psychotic, anxiolytic, and central nervous system inhibitory activities of EASA. In tests for anti-psychotic activity, EASA significantly increased the latency period for rats to climb a pole and increased cataleptic scores, indicating suppression of conditioned avoidance response activity, possibly by blocking dopaminergic pathways. In tests for anxiolytic activity, EASA significantly increased the number of entries and time spent in the open arms of an elevated plus maze, suggesting an increase in exploratory behavior. In tests of central nervous system activity
The document discusses herb-drug interactions (HDIs), providing background information and examples. It notes that HDIs are common due to many people using herbal medicines alongside conventional drugs. Herbal products can interact with drugs by interfering with the cytochrome P450 system and P-glycoprotein, affecting the metabolism and transport of drugs. This can change drug levels in the body and potentially cause toxic effects or reduce drug efficacy. The document examines several herbs that are known to interact with medications through these pathways and provides recommendations to avoid interactions and ensure patient safety when using herbal and conventional products together.
This document provides biographical and professional information about Dr. Nashwa Jarkas. It includes her contact information, education history, academic appointments, research focus, grants, publications, honors and awards, and professional service contributions. The document outlines that Dr. Jarkas received her PhD in synthetic organic-heterocyclic chemistry from the University of Metz in France. She has worked as an assistant professor at Emory University School of Medicine and her research focuses on developing radiotracers for neuroimaging and oncology using PET.
When to Conduct a Renal Impairment Studyshabeel pn
This document discusses the evaluation and labeling of drug interactions mediated by drug transporters. It proposes decision trees to determine if in vitro studies suggest a drug is a substrate or inhibitor of P-glycoprotein (P-gp) and may require in vivo interaction studies. It also provides examples of labeling transporter-mediated interactions and evaluates current knowledge for interactions via other transporters. Key questions are asked about the proposed decision trees and selection of inhibitors for in vivo studies.
Our goal is to provide an environment where patients are treated with the compassion and understanding they deserve. We want to make the process informative yet simple.
Folding: human protein atlas and artificial proteinsCristina Zuluaga
Researchers have created a human protein atlas that maps the locations of proteins in different human tissues. The atlas shows that almost half of all proteins are present in all body tissues and participate in many functions, while some proteins are specific to certain tissues like the brain, liver, and testes. This atlas could help increase the specificity of drugs by revealing why some drugs cause side effects. Additionally, scientists are designing artificial proteins that may help enhance medical imaging technologies like MRI and enable new targeted treatments by replacing or repairing proteins that cause diseases.
Revised Petition To The House Of CommonsEdward Dobson
The petition requests that the House of Commons hold a national referendum on the legalization of cannabis. It states that for most recreational users, cannabis does not pose health risks. It asks that cannabis and its derivatives be removed from acts regulating food and drugs. Signatures of support are collected from citizens across Canada.
13784156 Drug Decriminalization In Portugal Lessons For Creating Fair A...Edward Dobson
Portugal decriminalized drug possession and usage for personal use in 2001. This removed drug offenses from criminal law and made them administrative violations handled by special commissions, not the criminal justice system. These commissions typically suspend penalties for personal use and encourage treatment. Since decriminalization, drug usage rates have remained stable while related health and social problems have declined significantly. The policy has been widely embraced in Portugal as successful.
This experiment studied the effects of stress during puberty using rat models. Rats were subjected to stressful events known as juvenile social subjugation to model stress during puberty. Autoradiography was used to visualize CRF1 and CRF2 receptors in the brain which are involved in the stress response. The results found that the basolateral nucleus of the amygdala primarily expressed CRF1 receptors, while the medial preoptic nucleus secondarily expressed these receptors. The medial preoptic nucleus also expressed CRF2 receptors, but not as intensely as CRF1 receptors. Expression of both receptors increased with age and was generally higher in females compared to males. This supported the idea that females have a more plastic
This document provides information on the history, use, effects, and detection of marijuana. It begins with the origin of marijuana in Neolithic times in China or Central Asia and discusses its early uses as medicine and in social rituals. It then covers modern usage rates in the US population and among students. The document discusses the physiological and mental short-term effects of marijuana use as well as potential long-term health and mental health issues. It also outlines methods of detecting marijuana in the body and periods of detectability. Finally, it reviews diagnostic criteria for substance abuse and intoxication as defined by the DSM-IV-TR.
This document summarizes research on the neuroprotective effects of Stereospermum suaveolens DC. against Parkinson's disease and global cerebral ischemia in a rat model. Key findings include:
- S. suaveolens extract improved motor function and reduced Parkinson's disease symptoms in 6-OHDA induced rats in a dose-dependent manner based on latency, grooming, rearing, and ambulatory movement tests.
- The extract also reduced resting time in Parkinson's disease rats.
- Biochemical assays showed the extract reduced lipid peroxidation and increased antioxidant enzyme levels, suggesting it has neuroprotective effects through its antioxidant properties.
- Histopathological examination found the extract protected against
The document discusses cannabis (marijuana) and its components. It describes how cannabis originated in Central Asia and was introduced to other parts of the world. It discusses the different cannabinoids found in cannabis plants and synthesized in laboratories, including THC, CBD, and others. The document also outlines the mind and body effects of cannabis use and provides an overview of the laws and controversies around medicinal and recreational marijuana use.
[Final] Pharmacogenetics and Pharmacogenomics - WITH NOTESRaul Soto
This document summarizes a seminar presentation on the role of pharmacogenetics and pharmacogenomics in drug development and regulatory review. It discusses how genetic differences can impact how individuals metabolize and respond to drugs in terms of pharmacokinetics and pharmacodynamics. Factors like ethnicity, age, organ function, and genetics were presented as influencing a drug's effects. The role of metabolizing enzymes and transporters encoded by polymorphic genes in contributing to variability in drug responses and adverse events was emphasized. The importance of considering such genetic data during clinical trials and including relevant information in drug labels to allow for personalized dosing was also stressed.
Entactex Pharma Research Project_lap (3) (2)Lehel Simon
This document discusses research on the effects of nonapeptide agonists and antagonists on human and animal behavior. It describes how vasopressin and oxytocin receptors are located throughout the body and brain and influence various regulatory processes. The effects of agonists and antagonists that target different receptor subtypes are summarized, including their potential roles in conditions like aggression, anxiety, depression, diabetes, and social behaviors. The document also discusses genetic and epigenetic factors related to these neuropeptides and receptors.
This document summarizes a seminar presentation on the role of pharmacogenetics and pharmacogenomics in drug development and regulatory review. It discusses how genetic differences can impact how individuals metabolize and respond to drugs in terms of pharmacokinetics and pharmacodynamics. Specific polymorphisms in enzymes, receptors, and transporters were highlighted as factors that can influence a drug's effects. The importance of considering pharmacogenomic data during drug trials and regulatory reviews was emphasized in order to optimize dosing and labeling recommendations to improve drug efficacy and safety.
Classification of insecticide based on mode of action (1).pdfAsbinKatwal
Pesticides are chemicals used to control and eliminate pests that can cause damage to crops, human health, and the environment. There are various types of pesticides available in the market, and they are classified based on their mode of action, which refers to how the pesticide affects the target pest. Understanding the mode of action of pesticides is essential in choosing the right pesticide for a particular pest problem.
This document summarizes two scientific articles about recent discoveries related to gene regulation and potential new targets for treating prion diseases. The first article describes how scientists identified mystery sequences involved in gene regulation by RNA-binding proteins and the ribosome. The second reports that two compounds showed antiprion effects by binding to ribosomal RNA and inhibiting a protein, suggesting the ribosome is a new target for antiprion medicines. The document discusses the potential medical applications of further elucidating these genetic expression mechanisms.
International Journal of Clinical Pharmacology & Toxicology (IJCPT) ISSN:2167-910X is an Open Access journal, which aims to develop coherent means to modify drug therapy, with respect to the patient's genotype, and to ensure maximum efficiency with minimal contrary effects.
International Journal of Clinical Pharmacology & Toxicology (IJCPT) ISSN:2167-910X is an Open Access journal and a peer-reviewed journal. Clinical Pharmacology & Toxicology is the all-encompassing and becoming an increasingly important discipline for the identification of disease targets and drug designing with their toxicological effects and means to eradicate diseases.
Dr. Gabriel López-Berestein- Simposio Internacional 'Terapias oncológicas ava...Fundación Ramón Areces
Los días 15 y 16 de octubre de 2014, la Fundación Ramón Areces y la Real Academia Nacional de Farmacia, en colaboración con la Fundación de la Innovación Bankinter, reunieron en Madrid a algunos de los mayores expertos mundiales en nuevas terapias contra el cáncer. El Simposio Internacional, coordinado por la profesora y académica María José Alonso, analizó el momento actual de la lucha contra esta enfermedad. También fue un punto de encuentro para científicos de los más innovadores institutos de investigación en oncología, quienes debatieron sobre tres grandes temas: la Medicina Personalizada contra el cáncer, los nanomedicamentos en la terapia del cáncer y las terapias basadas en la inmunomodulación.
Maintaining adl’s in parkinson’s disease (final)dinkasfinest
The document summarizes research on the effects of an exercise intervention for patients with Parkinson's disease. It discusses an 8-subject study where participants underwent 3 one-hour exercise sessions per week for 6 months, focusing on balance, strength, technique and posture. Measures like gait, Parkinson's symptoms and quality of life were assessed before and after the intervention. The results showed improvements in these areas, suggesting exercise can help manage symptoms and quality of life for people living with Parkinson's disease.
The document summarizes a study that evaluated the psychopharmacological effects of the ethyl acetate extract of Sarcostemma acidum (EASA). Various tests were conducted to assess the anti-psychotic, anxiolytic, and central nervous system inhibitory activities of EASA. In tests for anti-psychotic activity, EASA significantly increased the latency period for rats to climb a pole and increased cataleptic scores, indicating suppression of conditioned avoidance response activity, possibly by blocking dopaminergic pathways. In tests for anxiolytic activity, EASA significantly increased the number of entries and time spent in the open arms of an elevated plus maze, suggesting an increase in exploratory behavior. In tests of central nervous system activity
The document discusses herb-drug interactions (HDIs), providing background information and examples. It notes that HDIs are common due to many people using herbal medicines alongside conventional drugs. Herbal products can interact with drugs by interfering with the cytochrome P450 system and P-glycoprotein, affecting the metabolism and transport of drugs. This can change drug levels in the body and potentially cause toxic effects or reduce drug efficacy. The document examines several herbs that are known to interact with medications through these pathways and provides recommendations to avoid interactions and ensure patient safety when using herbal and conventional products together.
This document provides biographical and professional information about Dr. Nashwa Jarkas. It includes her contact information, education history, academic appointments, research focus, grants, publications, honors and awards, and professional service contributions. The document outlines that Dr. Jarkas received her PhD in synthetic organic-heterocyclic chemistry from the University of Metz in France. She has worked as an assistant professor at Emory University School of Medicine and her research focuses on developing radiotracers for neuroimaging and oncology using PET.
When to Conduct a Renal Impairment Studyshabeel pn
This document discusses the evaluation and labeling of drug interactions mediated by drug transporters. It proposes decision trees to determine if in vitro studies suggest a drug is a substrate or inhibitor of P-glycoprotein (P-gp) and may require in vivo interaction studies. It also provides examples of labeling transporter-mediated interactions and evaluates current knowledge for interactions via other transporters. Key questions are asked about the proposed decision trees and selection of inhibitors for in vivo studies.
Our goal is to provide an environment where patients are treated with the compassion and understanding they deserve. We want to make the process informative yet simple.
Folding: human protein atlas and artificial proteinsCristina Zuluaga
Researchers have created a human protein atlas that maps the locations of proteins in different human tissues. The atlas shows that almost half of all proteins are present in all body tissues and participate in many functions, while some proteins are specific to certain tissues like the brain, liver, and testes. This atlas could help increase the specificity of drugs by revealing why some drugs cause side effects. Additionally, scientists are designing artificial proteins that may help enhance medical imaging technologies like MRI and enable new targeted treatments by replacing or repairing proteins that cause diseases.
Similar to Granny Storm Crows MMJ Reference List (20)
Revised Petition To The House Of CommonsEdward Dobson
The petition requests that the House of Commons hold a national referendum on the legalization of cannabis. It states that for most recreational users, cannabis does not pose health risks. It asks that cannabis and its derivatives be removed from acts regulating food and drugs. Signatures of support are collected from citizens across Canada.
13784156 Drug Decriminalization In Portugal Lessons For Creating Fair A...Edward Dobson
Portugal decriminalized drug possession and usage for personal use in 2001. This removed drug offenses from criminal law and made them administrative violations handled by special commissions, not the criminal justice system. These commissions typically suspend penalties for personal use and encourage treatment. Since decriminalization, drug usage rates have remained stable while related health and social problems have declined significantly. The policy has been widely embraced in Portugal as successful.
Oak Composition And Maturation InfluenceEdward Dobson
The document discusses the composition of oak and its influence on wine and spirit maturation. It provides details on the main constituents of oak - cellulose, hemicellulose, lignin, tannins, and lipids. During toasting, hemicellulose breaks down and produces compounds responsible for toasty flavors. Lignin breaks down into phenolic aldehydes and volatile phenols. Tannins enable oxidation during maturation. Oak lactones, highest in American white oak, contribute woody flavors especially in bourbon. Compounds are analyzed to understand the barrel influence on flavor.
The document discusses the history of chocolate, from its origins in Mesoamerica to its popularity in Europe. It details how the Maya and Aztecs cultivated the cocoa bean and used it in drinks. The Spanish conquest brought cocoa and chocolate drinks to Europe, where they became a trend among the elite before becoming more widely consumed as chocolate bars. The document provides background on the origins and spread of chocolate.
This document is the preface to "The Household Cyclopedia". It introduces the purpose and scope of the book, which is to provide practical knowledge and wisdom on domestic and social life through approved recipes and processes. The preface explains that the book aims to succinctly provide information on everything from manufacturing to health, using the best available authorities and sources. It also acknowledges several distinguished contributors who assisted in compiling the content.
This document provides an introduction to distillation, including:
1) Defining distillation and describing how it separates mixtures based on differences in boiling points.
2) Outlining the main components of distillation columns, including trays/plates, reboilers, condensers, and reflux drums.
3) Explaining the basic operation of distillation columns, including how vapors and liquids flow internally and how feeds, products, and reflux streams flow externally.
4) Describing common types of trays/plates used in distillation columns, including bubble cap, valve, and sieve trays, and how they enhance vapor-liquid contacting.
The Modern Survival Retreat A New And Vital Approach To Retreat Theory And ...Edward Dobson
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive functioning. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
This document provides a list of how to say "Cheers!" or toast to health in 66 different languages. It includes the phrase in each language's written form and pronunciation. The list was compiled in 1991 by Morten Larsen during research that involved sampling beers and wines from different cultures. Additions and corrections to the list are welcome through the comments form on the website.
The document describes the principles of distillation. It explains that distillation uses vapour pressure to separate mixtures based on their boiling points. A distillation column works more efficiently than a simple pot still by providing a greater surface area for vapor condensation through the use of packing materials like Raschig rings inside the column. This allows for a more complete separation of alcohol from other congeners during repeated distillations.
The document describes the principles of distillation. It explains that distillation uses vapour pressure to separate mixtures based on their boiling points. A distillation column works more efficiently than a simple pot still by providing a greater surface area for vapor condensation through the use of packing materials like Raschig rings inside the column. This allows for a more complete separation of alcohol from other congeners during repeated distillations.
Home Distillation Handbook How To Distill Quality Alcohol At Home Inexpensi...Edward Dobson
The document provides instructions for home distillation, including equipment, ingredients, and processes. It discusses fermentation vessels, lids, syphons, and measuring tools like hydrometers and alcohol meters. For distillation, it recommends a stainless steel still with a column. The column filling provides contact surface area and resistance for distillation. Proper temperature control is emphasized for distillation, and the document provides guidance on purification, flavoring, and legal issues related to home distillation.
1. The document discusses a research project that aimed to connect fruit growers with surplus fruit to wineries interested in making fruit brandy. The goal was to provide an alternative market for excess crops and develop new products for wineries.
2. Researchers educated growers and vintners on distillery operations through demonstrations. One Missouri winery established a distillery and contracted with local growers for surplus fruit.
3. Researchers assessed distillery techniques by visiting operations in other places. They produced fruit brandies from apples and peaches grown at a state experiment station to develop a new value-added product for Missouri.
The document provides a description and calculation process for a correction table for an alcoholometer calibrated at 20°C. It involves:
1) Creating matrices to relate ethanol concentration and density at various temperatures based on polynomial fits of experimental data tables.
2) Using the relationships and a linearization of volume change with temperature to calculate density corrections for different concentrations and temperatures.
3) Converting the corrected densities back to ethanol concentrations to populate the correction table, which lists the actual concentration for a given measured concentration at various temperatures.
This document discusses different types of distillation stills that can be built at home, beginning with pot stills. Pot stills are the simplest type of still but are inefficient and produce impure distillate due to a lack of temperature and separation controls. They work best for separating compounds with a 100 degree Celsius boiling point difference. Repeated distillations are required in a pot still to achieve purity, resulting in significant product loss. More advanced still designs like reflux stills allow for better separation and purity in fewer distillation runs.
The document provides teachings from Church leaders about the importance of emergency preparedness and self-reliance. Some key points include:
- Church leaders have counseled Saints for over 100 years to store up grain and have a year's supply of food and necessities.
- Wheat and water are identified as high priorities. Other basics include honey, sugar, legumes, milk products, and salt.
- Proper storage allows Latter-day Saints to avoid being dependent on others during times of shortage.
- Individuals and families should take responsibility for their own welfare and preparedness.
Small Scale Preparation Of Dairy Products Probiotics Yogurts Cheese Butter Bu...Edward Dobson
This document provides an introduction to small-scale dairy processing using simple techniques. It discusses why processing milk into dairy products can be beneficial when there is a surplus of milk. Some key points:
- Processing milk allows for products with longer shelf lives to be created and sold when fresh milk is not needed or cannot reach markets. This can increase financial gains.
- Many populations cannot consume fresh milk due to lactose intolerance, but dairy products where the lactose is reduced can be digested.
- High temperatures and humidity in tropical climates present challenges for processing and storage, so choosing appropriate products is important. Thorough cleaning and hygiene is also essential to prevent contamination.
- The manual provides
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
ABDOMINAL TRAUMA in pediatrics part one.drhasanrajab
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Top Effective Soaps for Fungal Skin Infections in India
Granny Storm Crows MMJ Reference List
1. Granny Storm Crow's MMJ Reference List
It Is Time for Marijuana to Be Reclassified as Something Other Than a Schedule I Drug! (2005)
http://www.pubmedcentral.nih.gov/art...tool=pmcentrez
ACEA- see ARACHIDONYL-2'-CHLOROETHYLAMIDE
ADD/ ADHD
ADHD by Ryan P (anecdotal - no date)
http://www.rxmarijuana.com/shared_comments/ADHD4.htm
Marijuana and ADD Therapeutic uses of Medical Marijuana in the treatment of ADD (no date)
http://www.onlinepot.org/medical/add&mmj.htm
Recipe For Trouble (anecdotal/ news - 2002 )
http://www.cbsnews.com/stories/2002/...in503022.shtml
Association between cannabinoid receptor gene (CNR1) and childhood attention deficit/hyperactivity
disorder in Spanish male alcoholic patients (full - 2003)
http://www.nature.com/mp/journal/v8/.../4001278a.html
Cannabinoids effective in animal model of hyperactivity disorder (abst - 2003)
http://www.cannabis-med.org/english/...l.php?id=162#4
Cannabis 'Scrips to Calm Kids? (news - 2004)
http://www.foxnews.com/story/0,2933,117541,00.html
Fitness to drive in spite (because) of THC (abst - 2007)
http://www.unboundmedicine.com/medli...use__of_THC%5D
Science: THC normalized impaired psychomotor performance and mood in a patient with hyperactivity
disorder (news - 2007)
http://www.cannabis-med.org/english/...kel.php?id=254
Association of the Cannabinoid Receptor Gene (CNR1) With ADHD and Post-Traumatic Stress Disorder
(full - 2008)
http://www.ncbi.nlm.nih.gov/pmc/arti...6/?tool=pubmed
Cannabis Improves Symptoms of ADHD (full - 2008)
http://www.cannabis-med.org/english/..._2008_01_1.pdf
Cannabis use and adult ADHD symptoms. (abst - 2008)
http://www.ncbi.nlm.nih.gov/pubmed/18242878
Autism, ADD, ADHD and Marijuana Therapy (news - 2008)
http://www.entheology.org/edoto/anmviewer.asp?a=319
2. Why I Give My 9-year-old Pot (anecdotal/news - 2009)
http://www.doublex.com/section/healt...9-year-old-pot
Why I Give My 9-Year-Old Pot, Part II (news/anecdotal - 2009)
http://www.doublex.com/section/healt...ld-pot-part-ii
ADDICTION RISK- PHYSICAL
Women's Guide to the UofC (no date)
http://wguide.uchicago.edu/9substance.html
Cannabis Basics (no date)
http://www.erowid.org/plants/cannabi...s_basics.shtml
10 Things Every Parent, Teenager & Teacher Should Know About Marijuana (4th Question) (no date)
http://www.erowid.org/plants/cannabi...s_flyer1.shtml
Marijuana Myths, Claim No. 9 (no date)
http://www.erowid.org/plants/cannabi...is_myth9.shtml
Excerpt from the Merck Manual (excerpt - 1987)
http://www.ukcia.org/research/merck.htm
Relative Addictiveness of Various Substances (full - 1990)
http://www.ukcia.org/research/addictiv.htm
Anandamide, an Endogenous Cannabinoid, Has a Very Low Physical Dependence Potential (full - 1998)
http://jpet.aspetjournals.org/conten...urcetype=HWCIT
Dependency and Cannabis (full - 1999)
http://www.mikuriya.com/cw_depend.html
Chronic Morphine Modulates the Contents of the Endocannabinoid, 2-Arachidonoyl Glycerol, in Rat
Brain (full - 2003)
http://www.nature.com/npp/journal/v2.../1300117a.html
Long term marijuana users seeking medical cannabis in California (2001–2007): demographics, social
characteristics, patterns of cannabis and other drug use of 4117 applicants (full - 2007)
http://www.harmreductionjournal.com/content/4/1/16
Lack of behavioral sensitization after repeated exposure to THC in mice and comparison to
methamphetamine (full - 2007)
http://www.ncbi.nlm.nih.gov/pmc/arti...2/?tool=pubmed
Merck Manual - Marijuana (Cannabis) (excerpt - 2008)
http://www.merck.com/mmpe/sec15/ch19...nabinol&alt=sh
Study of 4000 indicates marijuana discourages use of hard drugs. (news - 2008)
http://www.csdp.org/publicservice/medicalmj08.htm
3. Adolescent Exposure to Chronic Delta-9-Tetrahydrocannabinol Blocks Opiate Dependence in Maternally
Deprived Rats (abst - 2009)
http://www.nature.com/npp/journal/va...pp200970a.html
The Surprising Effect Of Marijuana On Morphine Dependence (news - 2009)
http://www.redorbit.com/news/health/...ne_dependence/
Active Ingredient In Cannabis Eliminates Morphine Dependence In Rats
(news- 2009)
http://www.sciencedaily.com/releases...0706090440.htm
2-AG - see 2-ARACHIDONOYLGLYCEROL
AGING /USE BY SENIORS
The Peripheral Cannabinoid Receptor CB2 and CD40 Are Novel Biological Markers That Predict Outcome
in Diffuse Large B-Cell Lymphoma of Elderly Patients. (abst - 2004)
http://abstracts.hematologylibrary.o...urcetype=HWCIT
Pass the Doobie, pops (news - 2005)
http://findarticles.com/p/articles/m.../ai_n32034523/
Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats (full - 2007)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Inflammation and aging: can endocannabinoids help? (full - 2008)
http://www.pubmedcentral.nih.gov/art...tool=pmcentrez
Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats (full - 2008)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Aging and chronic pain using medical marijuana (article - 2008)
http://www.medical-marijuana-testimo...-marijuana.htm
Cannabis and Alzheimer's disease (article - 2008)
http://www.medical-marijuana-testimo...-and-movement-
disorders-medical-marijuana.htm
Cannabis and movement disorders (article - 2008)
http://www.medical-marijuana-testimo...-marijuana.htm
Cannabinoids Attenuate the Effects of Aging Upon Neuroinflammation and Neurogenesis. (abst - 2008)
http://www.cannabisscience.com/resea...nti-aging.html
CN BC: Expert Testifies Cannabis Helps Slow Aging (news - 2008)
http://www.mapinc.org/drugnews/v08/n458/a05.html
4. Could Marijuana Substance Help Prevent Or Delay Memory Impairment In The Aging Brain? (news -
2008)
http://www.sciencedaily.com/releases...1119120141.htm
Marijuana may be good for the aging brain (news - 2008)
http://www.news-medical.net/news/2008/11/19/43212.aspx
Older Adults' Pot Use Up (news - 2010)
http://www.mapinc.org/drugnews/v10/n138/a02.html?1189
Marijuana Use By Seniors Goes Up As Boomers Age (news - 2010)
http://www.mapinc.org/drugnews/v10/n136/a01.html?1189
Pot Breaks the Age Barrier (news - 2010)
http://www.mapinc.org/drugnews/v10/n233/a01.html?1190
AIDS – see HIV
AJULEMIC ACID/ IP-751 - a side-chain synthetic analog of Δ8-THC-11-oic acid
Marijuana-Derived Compound Targets Pain, Inflammation (news - 2002)
http://www.sciencedaily.com/releases...0822071026.htm
Ajulemic Acid (IP-751): Synthesis, Proof of Principle, Toxicity Studies, and Clinical Trials (full - 2004)
http://www.aapsj.org/view.asp?art=aapsj070115
Ajulemic acid: A novel cannabinoid produces analgesia without a “high”
(abst - 2004)
http://www.ncbi.nlm.nih.gov/pubmed/1...?dopt=Abstract
Ajulemic acid (IP-751): Synthesis, proof of principle, toxicity studies, and clinical trials (abst - 2005)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Marijuana-Derived Drug Suppresses Bladder Overactivity And Irritation In Animal Models (news - 2005)
http://www.sciencedaily.com/releases...0906080225.htm
Cannabimimetic Properties of Ajulemic Acid (full - 2006)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Marijuana-Derived Drug Suppresses Bladder Pain In Animal Models
(news - 2006)
http://www.sciencedaily.com/releases...0521103039.htm
Cannabimimetic Properties of Ajulemic Acid (full - 2007)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2633725/
In humans, ajulemic acid has a more favorable side-effect profile than THC for the treatment of chronic
neuropathic pain (full - 2007)
5. http://www.cannabis-med.org/english/..._2007_01_1.pdf
Letter: Preclinical assessment of abuse liability of ajulemic acid (letter - 2007)
http://www.cannabis-med.org/english/..._2007_01_2.pdf
Suppression of fibroblast metalloproteinases by ajulemic acid, a nonpsychoactive cannabinoid acid.
(abst - 2007)
http://www.ncbi.nlm.nih.gov/pubmed/16927387
Effects of IP-751, ajulemic acid, on bladder overactivity induced by bladder irritation in rats. (abst - 2007)
http://www.ncbi.nlm.nih.gov/pubmed/17656248
Ajulemic acid, a nonpsychoactive cannabinoid acid, suppresses osteoclastogenesis in mononuclear
precursor cells and induces apoptosis in mature osteoclast-like cells. (abst - 2008)
http://www.ncbi.nlm.nih.gov/pubmed/17786950
Suppression of human macrophage interleukin-6 by a nonpsychoactive cannabinoid acid. (abst - 2008)
http://www.ncbi.nlm.nih.gov/sites/pubmed
Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation
(full - 2009)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-
inflammatory eicosanoid, lipoxin A4 (full - 2009)
http://www.fasebj.org/cgi/content/fu...urcetype=HWCIT
ALCOHOLISM
Cannabis substitution: An Adjunctive Therapeutic Tool in the Treatment of Alcoholism (full - 1969)
http://www.mikuriya.com/s3_7.pdf
Association between cannabinoid receptor gene (CNR1) and childhood attention deficit/hyperactivity
disorder in Spanish male alcoholic patients (full - 2003)
http://www.nature.com/mp/journal/v8/.../4001278a.html
Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-
dependent decline in mice (full - 2003)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Cannabis as a Substitute for Alcohol (full - 2003)
http://ccrmg.org/journal/03sum/substitutealcohol.html
Comparison of Cannabidiol, Antioxidants, and Diuretics in Reversing Binge Ethanol-Induced
Neurotoxicity (full - 2005)
http://jpet.aspetjournals.org/content/314/2/780.full
Role of cannabinoid receptors in alcohol abuse (news - 2005)
6. http://www.medicalnewstoday.com/articles/30338.php
Effects of Alcohol and Combined Marijuana and Alcohol Use During Adolescence on Hippocampal
Volume and Asymmetry (full - 2006)
http://www.ncbi.nlm.nih.gov/pmc/arti...2/?tool=pubmed
The endocannabinoid signaling system: a potential target for next-generation therapeutics for
alcoholism (full - 2007)
http://www.pubmedcentral.nih.gov/art...?artid=1975858
Report: Marijuana Less Harmful than Alcohol or Tobacco (news - 2008)
http://www.jointogether.org/news/hea...uana-less.html
Cannabis reverses brain damage from alcohol (news - 2008)
http://medicalcannabisawareness.mybl...ry36.html#body
Cannabis as a substitute for alcohol and other drugs. (full - 2009)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Daily marijuana users with past alcohol problems increase alcohol consumption during marijuana
abstinence. (abst - 2009)
http://www.unboundmedicine.com/medli...na_abstinence_
White Matter Integrity in Adolescents with Histories of Marijuana Use and Binge Drinking. (abst - 2009)
http://www.unboundmedicine.com/medli...inge_Drinking_
Pot Might Blunt Damage of Binge Drinking (news - 2009)
http://www.healthday.com/Article.asp?AID=630296
Maternal Marijuana use not Associated with Psychotic Symptoms , but Alcohol is
(news - 2009)
http://ohiopatientsnetwork.org/index...id=3:newsflash
Cannabis as a substitute for heavy alcohol usage? (news - 2009)
http://www.news-medical.net/news/200...hol-usage.aspx
Marijuana To Control Alcohol Abuse (news - 2010)
http://psychcentral.com/news/2009/12...buse/9863.html
Study shows direct cellular interaction between endocannabinoids and alcohol in the brain (news -
2010)
http://www.news-medical.net/news/201...the-brain.aspx
ALLERGIES AND CANNABIS
Allergy to Marihuana (abst - 1971)
http://www.annals.org/content/75/4/5...urcetype=HWCIT
7. Allergic Skin Test Reactivity to Marijuana in the Southwest (full - 1983)
http://www.pubmedcentral.nih.gov/art...tool=pmcentrez
Allergenic properties of naturally occurring cannabinoids. (abst - 1983)
http://www.ncbi.nlm.nih.gov/pubmed/6620158
Marijuana smoking and fungal sensitization. (abst - 1983)
http://www.ncbi.nlm.nih.gov/pubmed/6833678
Cannabis (hemp) positive skin tests and respiratory symptoms (abst - 1999)
http://www.sciencedirect.com/science...920d8be32ac3af
Allergic rhinoconjunctivitis caused by Cannabis sativa pollen (full- 2007)
http://www.jiaci.org/issues/vol18issue1/13-17.pdf
Attenuation of Allergic Contact Dermatitis Through the Endocannabinoid System
(full - 2008)
http://pediatrics.aappublications.or...urcetype=HWCIT
Constituents Of Hashish And Marijuana May Help To Fight Inflammation And Allergies (news - 2007)
http://www.sciencedaily.com/releases...0607171120.htm
Marijuana Might Help Cure Allergic Contact Dermatitis (a.k.a. Poison Ivy)
(news - 2007)
http://www.healthcentral.com/skin-ca...ure-aka-ivy/1/
Cannabis for allergic contact dermatitis (news - 2007)
http://www.news-medical.net/news/2007/08/17/28901.aspx
Constituents Of Hashish And Marijuana May Help To Fight Inflammation And Allergies (news - 2007)
http://www.sciencedaily.com/releases...0607171120.htm
Sensitization and Allergy to Cannabis sativa Leaves in a Population of Tomato Sensitized Patients. (abst -
2008)
http://marijuana.researchtoday.net/archive/5/2/1629.htm
Hemp: A replacement for common food allergens? (news - 2009)
http://www.examiner.com/x-20151-Manc...food-allergens
ALS / AMYOTROPHIC LATERAL SCLEROSIS
Marijuana in the management of amyotrophic lateral sclerosis (abst - 2001)
http://ajh.sagepub.com/cgi/content/a...urcetype=HWCIT
Survey of cannabis use in patients with amyotrophic lateral sclerosis.
(abst - 2004)
http://ajh.sagepub.com/cgi/content/a...urcetype=HWCIT
8. Delayed disease progression in ALS mice by treatment with a cannabinoid.
(abst on forum - 2004)
http://sci.rutgers.edu/forum/archive...php/t-557.html
Cannabis' Potential Exciting Researchers in Treatment of ALS, Parkinson's Disease -URB597 (news - 2004)
http://www.illinoisnorml.org/index2....o_pdf=1&id=104
Cannabis Relieves Lou Gehrigs Symptoms - New Study (news - 2004)
http://www.rense.com/general51/lou.htm
Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival. (abst -
2005)
http://www.ncbi.nlm.nih.gov/sites/en..._uids=16183560
Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in
SOD1 mice (full - 2006)
http://www.fasebj.org/cgi/content/full/20/7/1003
The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic
lateral sclerosis when initiated at symptom onset
(full - 2007)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
The endocannabinoid system in targeting inflammatory neurodegenerative diseases (full - 2007)
http://medicalcannabis.com/images/pd...tory_neuro.pdf
Emerging Role of the CB2 Cannabinoid Receptor in Immune Regulation and Therapeutic Prospects (full -
2009)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Cannabinoids as Therapeutic Agents for Ablating Neuroinflammatory Disease (full - 2009)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
The endocannabinoid system in amyotrophic lateral sclerosis. (abst - 2009)
http://www.ncbi.nlm.nih.gov/pubmed/18781981
Cannabis and Amyotrophic Lateral Sclerosis: Hypothetical and Practical Applications, and a Call for
Clinical Trials. (abst - 2010)
http://www.ncbi.nlm.nih.gov/pubmed/20439484
Marijuana May Extend Life Expectancy Of Lou Gehrig's Disease Patients, Study Says (news - 2010)
http://www.enewspf.com/index.php/lat...ts-study-says-
ALZHEIMER'S DISEASE
My Mother and Alzheimer’s (anecdotal - no date)
http://www.jackherer.com/mom.html
9. Marijuana reduces memory impairment (news - no date)
http://www.healthnewstrack.com/health-news-811.html
Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease. (abst -
1997)
http://www.cannabis-med.org/studies/...ow.php?s_id=59
US Patent 6630507 - Cannabinoids as antioxidants and neuroprotectants
(full - 2003)
http://www.patentstorm.us/patents/6630507.html
Safety and efficacy of Dronabinol in the treatment of agitation in patients with Alzheimer’s disease with
anorexia (abst - 2003)
http://www.cannabis-med.org/studies/...ow.php?s_id=61
Open-label study of Dronabinol in the treatment of refractory agitation in Alzheimer’s disease : a pilot
study (abst - 2003)
http://www.cannabis-med.org/studies/...ow.php?s_id=92
Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on β-
amyloid-induced toxicity in PC12 cells (full - 2004)
http://www3.interscience.wiley.com/c...7302/HTMLSTART
Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade
of Microglial Activation (full - 2005)
http://www.jneurosci.org/cgi/content/full/25/8/1904
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
(full - 2005)
http://www.jneuroinflammation.com/content/2/1/29
Marijuana Ingredient May Stall Decline From Alzheimer's (news - 2005)
http://www.sciencedaily.com/releases...0224111638.htm
Marijuana Slows Alzheimer's Decline (news - 2005)
http://www.mapinc.org/drugnews/v05/n307/a10.html
Marijuana May Block Alzheimer's (news - 2005)
http://news.bbc.co.uk/2/hi/health/4286435.stm
Marijuana Ingredient May Help Alzheimer's (news - 2005)
http://www.webmd.com/alzheimers/news...elp-alzheimers
Cannabinoids reduce the progression of Alzheimer's disease in animals
(news - 2005)
http://www.cannabis-med.org/english/...l.php?id=187#1
Pass the Doobie, pops (news - 2005)
10. http://findarticles.com/p/articles/m.../ai_n32034523/
Cannabis therapy (news - 2005)
http://findarticles.com/p/articles/m...g=content;col1
The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration (full - 2006)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Molecular Link between the Active Component of Marijuana and Alzheimer's Disease Pathology (full -
2006)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia
(full - 2006)
http://science.iowamedicalmarijuana....her%202006.pdf
THC inhibits primary marker of Alzheimer's disease (news - 2006)
http://www.cannabis-med.org/english/...l.php?id=225#3
Marijuana's Active Ingredient May Slow Progression Of Alzheimer's Disease
(news - 2006)
http://www.sciencedaily.com/releases...1009031544.htm
Marijuana may help stave off Alzheimer’s (news - 2006)
http://www.msnbc.msn.com/id/15145917/
Marijuana May Slow Alzheimer's (news - 2006)
http://www.webmd.com/alzheimers/news...low-alzheimers
Pot-Like Compound May Slow Alzheimer's (news - 2006)
http://www.webmd.com/alzheimers/news...low-alzheimers
Latest Buzz: Marijuana May Slow Progression Of Alzheimer's Disease
(news - 2006)
http://www.sciencedaily.com/releases...1018151055.htm
Alzheimer's disease; taking the edge off with cannabinoids? (full - 2007)
http://www.pubmedcentral.nih.gov/art...medid=17828287
Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS
expression (full - 2007)
http://www.pubmedcentral.nih.gov/art...tool=pmcentrez
Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain
inflammation (full - 2007)
http://www.pubmedcentral.nih.gov/art...tool=pmcentrez
The endocannabinoid system in targeting inflammatory neurodegenerative diseases (full - 2007)
11. http://medicalcannabis.com/images/pd...tory_neuro.pdf
Cannabinoid CB2 receptors in human brain inflammation (full - 2008)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219537/
Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats (full - 2008)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Cannabinoids as Therapeutic Agents for Ablating Neuroinflammatory Disease (full - 2008)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Inflammation and aging: can endocannabinoids help? (full - 2008)
http://www.pubmedcentral.nih.gov/art...tool=pmcentrez
Cannabis and Alzheimer's disease (article - 2008)
http://www.medical-marijuana-testimo...-and-movement-
disorders-medical-marijuana.htm
Marijuana may be good for the aging brain (news - 2008)
http://www.news-medical.net/news/2008/11/19/43212.aspx
Alzheimer's sufferers may benefit from cannabis compound (news - 2008)
http://www.news-medical.net/news/2008/03/11/36068.aspx
Cannabis 'could stop dementia in its tracks' (news - 2008)
http://www.dailymail.co.uk/health/ar...ia-tracks.html
Could Marijuana Substance Help Prevent Or Delay Memory Impairment In The Aging Brain? (news -
2008)
http://www.sciencedaily.com/releases...1119120141.htm
Attacking Alzheimer's with Red Wine and Marijuana (news - 2008)
http://www.alternet.org/story/110806/
Pot joins the fight against Alzheimer's, memory loss (news - 2008)
http://www.scientificamerican.com/bl...eim-2008-11-19
Can cannabis offer hope for Alzheimer's? (news - 2008)
http://findarticles.com/p/articles/m...g=content;col1
Cannabis-derived medicines may help Alzheimer's (news - 2008)
http://www.news-medical.net/news/2008/03/10/36024.aspx
Emerging Role of the CB2 Cannabinoid Receptor in Immune Regulation and Therapeutic Prospects (full -
2009)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by
12. human macrophages. (abst - 2009)
http://www.ncbi.nlm.nih.gov/pubmed/1...&ordinalpos=18
Marijuana could prevent Alzheimer's (news - 2010)
http://www.thelantern.com/mobile/2.1...imer-s-1.72932
AM-251 - a synthetic CB1 antagonist
Inhibition of Rat C6 Glioma Cell Proliferation by Endogenous and Synthetic Cannabinoids. Relative
Involvement of Cannabinoid and Vanilloid Receptors
(full - 2001)
http://jpet.aspetjournals.org/content/299/3/951.full
Influence of the CB1 receptor antagonist, AM 251, on the regional haemodynamic effects of
WIN-55212-2 or HU 210 in conscious rats
(full - 2002)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
CB1 cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents
endothelial dysfunction and hypotension in rats with myocardial infarction (full - 2003)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery (full - 2003)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury:
involvement of cytokine/chemokines and PMN (full - 2003)
http://www.jleukbio.org/cgi/content/...urcetype=HWCIT
Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in
lipopolysaccharide-treated rats (full - 2004)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Up-Regulation of Cyclooxygenase-2 Expression Is Involved in R(_)-Methanandamide-Induced Apoptotic
Death of Human Neuroglioma Cells
(full - 2004)
http://science.iowamedicalmarijuana....inz%202004.pdf
The cannabinoid 1 receptor antagonist, AM251, prolongs the survival of rats with severe acute
pancreatitis. (full - 2005)
http://www.jstage.jst.go.jp/article/...07_99/_article
Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal
culture model of acquired epilepsy (full - 2006)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
AM 251 produces sustained reductions in food intake and body weight that are resistant to tolerance
and conditioned taste aversion (full - 2006)
13. http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Antinociceptive effect of cannabinoid agonist WIN 55,212–2 in rats with a spinal cord injury (full - 2006)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Inhibition of Salivary Secretion by Activation of Cannabinoid Receptors
(full - 2006)
http://ebm.rsmjournals.com/cgi/conte...urcetype=HWCIT
Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats (full - 2007)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
CANNABINOID-INDUCED HYPERPHAGIA: CORRELATION WITH INHIBITION OF PROOPIOMELANOCORTIN
NEURONS? (full - 2007)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Cannabinoid action in the olfactory epithelium (full - 2007)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Cannabinoids Inhibit HIV-1 Gp120-Mediated Insults in Brain Microvascular Endothelial Cells (full - 2008)
http://www.jimmunol.org/cgi/content/...urcetype=HWCIT
Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids:
Involvement of Regulatory T Cells (full - 2008)
http://molpharm.aspetjournals.org/co...#content-block
Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats (full -
2008)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Activating Parabrachial Cannabinoid CB1 Receptors Selectively Stimulates Feeding of Palatable Foods in
Rats (full - 2008)
http://www.jneurosci.org/cgi/content...urcetype=HWCIT
Feeding induced by cannabinoids is mediated independently of the melanocortin system. (full - 2008)
http://www.ncbi.nlm.nih.gov/pmc/arti...0/?tool=pubmed
Loss of cannabinoid receptor 1 accelerates intestinal tumor growth (full - 2008)
http://www.ncbi.nlm.nih.gov/pmc/arti...8/?tool=pubmed
Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and
non-fasted mice (full - 2009)
http://www.ncbi.nlm.nih.gov/pmc/arti...5/?tool=pubmed
Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable
glucocorticoid modulation of memory (full - 2009)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
14. Effects of the cannabinoid CB1 receptor antagonist AM 251 on the reinstatement of nicotine-
conditioned place preference by drug priming in rats. (abst - 2009)
http://www.unboundmedicine.com/medli...iming_in_rats_
Spinal and peripheral analgesic effects of the CB cannabinoid receptor agonist AM1241 in two models of
bone cancer-induced pain. (abst - 2010)
http://www.ncbi.nlm.nih.gov/pubmed/20233215
AM-404 - a synthetic CB1 agonist
Synergistic Interactions between Cannabinoids and Environmental Stress in the Activation of the Central
Amygdala (full - 2005)
http://www.nature.com/npp/journal/v3.../1300535a.html
Enhancing Cannabinoid Neurotransmission Augments the Extinction of Conditioned Fear (full - 2005)
http://www.nature.com/npp/journal/v3.../1300655a.html
Δ9-Tetrahydrocannabinol (THC) and AM 404 protect against cerebral ischaemia in gerbils through a
mechanism involving cannabinoid and opioid receptors
(full - 2007)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
AM-630 - a synthetic CB2 antagonist
Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury:
involvement of cytokine/chemokines and PMN (full - 2003)
http://www.jleukbio.org/cgi/content/...urcetype=HWCIT
Antinociceptive effect of cannabinoid agonist WIN 55,212–2 in rats with a spinal cord injury (full - 2006)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Inhibition of Salivary Secretion by Activation of Cannabinoid Receptors
(full - 2006)
http://ebm.rsmjournals.com/cgi/conte...urcetype=HWCIT
Regulation of Bone Mass, Osteoclast Function, and Ovariectomy-Induced Bone Loss by the Type 2
Cannabinoid Receptor (full - 2008)
http://endo.endojournals.org/cgi/con...urcetype=HWCIT
Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids:
Involvement of Regulatory T Cells (full - 2008)
http://molpharm.aspetjournals.org/co...#content-block
Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic
Steatosis (full - 2009)
http://www.ncbi.nlm.nih.gov/pmc/arti...0/?tool=pubmed
AM-1241 - a synthetic CB 2 agonist
15. Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain
inhibition by receptors not present in the CNS (full - 2003)
http://www.pnas.org/content/100/18/10529.full
New Compound That Acts On Peripheral Receptors May Be Promising Treatment For Some Nerve Pain
(news - 2003)
http://www.sciencedaily.com/releases...0812073750.htm
CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of
endogenous opioids (full - 2005)
http://www.pnas.org/content/102/8/3093.full
The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic
lateral sclerosis when initiated at symptom onset
(full - 2007)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by
Treatment with the Chemotherapeutic Agent Paclitaxel in Rats (full - 2008)
http://jpet.aspetjournals.org/conten...#content-block
Peripheral Cannabinoids Attenuate Carcinoma Induced Nociception in Mice
(full - 2008)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771220/
Spinal and peripheral analgesic effects of the CB cannabinoid receptor agonist AM1241 in two models of
bone cancer-induced pain. (abst - 2010)
http://www.ncbi.nlm.nih.gov/pubmed/20233215
A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss. (abst - 2010)
http://www.ncbi.nlm.nih.gov/pubmed/20176037
AM-1346 - a synthetic CB1 agonist
Synthetic Cannabinoid May Aid Fertility In Smokers (news - 2006)
http://www.medicalnewstoday.com/articles/58063.php
Marijuana-like Chemical Can Restore Sperm Function Lost to Tobacco Abuse
(news - 2006)
http://www.rxpgnews.com/specialtopic...cle_5093.shtml
Cannabis-based boost for smokers' suffering sperm (news - 2006)
http://www.newscientist.com/article/...ing-sperm.html
Scientist Discovers New Molecule to Treat Chronic Pain (news - 2008)
http://www.physorg.com/news137778721.html
16. AM- 4054 - a synthetic CB1 agonist
Effects of a Selective Cannabinoid Agonist and Antagonist on Body Temperature in Rats (abst - 2007)
http://www.fasebj.org/cgi/content/me...urcetype=HWCIT
AM- 4113 - a synthetic CB1 antagonist
Effects of a Selective Cannabinoid Agonist and Antagonist on Body Temperature in Rats (abst - 2007)
http://www.fasebj.org/cgi/content/me...urcetype=HWCIT
AMOTIVATIONAL SYNDROME
Marihuana Use and Psychosocial Adaptation (abst - 1974)
http://archpsyc.ama-assn.org/cgi/con...urcetype=HWCIT
Operant acquisition of marihuana in man. (abst - 1976)
http://jpet.aspetjournals.org/conten...urcetype=HWCIT
Cannabis amotivational syndrome and personality trait absorption: A review and reconceptualization
(full - 1994)
http://www.ukcia.org/research/Person...Absorption.php
Debunking the Amotivational Syndrome (news - 1995)
http://www.drugscience.org/Petition/C3F.html
Amotivational Syndrome (book excerpt - 2000)
http://leda.lycaeum.org/?ID=12454
Cannabis, motivation, and life satisfaction in an internet sample (full - 2006)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Debunking "Amotivational Syndrome" (news - 2006)
http://www.mapinc.org/drugnews/v06/n400/a06.html
Cannabis Use Not Linked To So-Called "Amotivational Syndrome"
(news - 2006)
http://norml.org/index.cfm?Group_ID=6824
ANANDAMIDE / AEA - an endocannabinoid
Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN
55,212-2 and anandamide. (full - 1993)
http://www.ncbi.nlm.nih.gov/pmc/arti...centrez&page=1
Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid
receptor and stimulates receptor-mediated signal transduction
(full - 1993)
http://www.pnas.org/content/90/16/7656.full.pdf+html
17. Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain
membranes (full - 1994)
http://www.pnas.org/content/91/14/6698.full.pdf+html
Anandamide and delta 9-THC dilation of cerebral arterioles is blocked by indomethacin (abst - 1995)
http://ajpheart.physiology.org/cgi/c...urcetype=HWCIT
Cannabinoid-Induced Hypotension and Bradycardia in Rats Is Mediated by CB1-Like Cannabinoid
Receptors (full - 1997)
http://jpet.aspetjournals.org/conten...urcetype=HWCIT
Brain Chemicals Mimic Marijuana (news - 1997)
http://www.ukcia.org/research/anandami.php
Anandamide, an Endogenous Cannabinoid, Has a Very Low Physical Dependence Potential (full - 1998)
http://jpet.aspetjournals.org/conten...urcetype=HWCIT
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation (full - 1998)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC20983/
Doped skin (news - 1998)
http://www.newscientist.com/article/...oped-skin.html
Pain modulation by release of the endogenous cannabinoid anandamide
(full - 1999)
http://www.pnas.org/content/96/21/12198.full
Brain Releases Marijuana-Like Substance In Response To Pain, Study Finds
(news - 1999)
http://www.sciencedaily.com/releases...1013074947.htm
UC Irvine Researchers Demonstrate How Marijuana-Like Chemicals Work In The Brain (news - 1999)
http://www.sciencedaily.com/releases...0323050735.htm
Why your brain is primed for a high (news - 1999)
http://www.newscientist.com/article/...or-a-high.html
Anandamide Induces Apoptosis in Human Cells via Vanilloid Receptors
(full - 2000)
http://www.jbc.org/content/275/41/31938.full
Endocannabinoids and Vascular Function (full - 2000)
http://jpet.aspetjournals.org/content/294/1/27.long
Suppression of Nerve Growth Factor Trk Receptors and Prolactin Receptors by Endocannabinoids Leads
to Inhibition of Human Breast and Prostate Cancer Cell Proliferation (full - 2000)
http://endo.endojournals.org/cgi/content/full/141/1/118
18. Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues
isolated from rat, mouse, pig, dog, monkey and human
(full - 2000)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Cardiovascular effects of endocannabinoids--the plot thickens. (abst - 2000)
http://www.ncbi.nlm.nih.gov/sites/en...t=abstractplus
Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of
intestinal inflammation (full - 2001)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Inhibition of Rat C6 Glioma Cell Proliferation by Endogenous and Synthetic Cannabinoids. Relative
Involvement of Cannabinoid and Vanilloid Receptors
(full - 2001)
http://jpet.aspetjournals.org/content/299/3/951.full
Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats (full - 2001)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase
and enhances the anti-proliferative effect of anandamide in human breast
cancer cells (full - 2001)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries (full - 2001)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction (full - 2001)
http://content.onlinejacc.org/cgi/co...urcetype=HWCIT
Anandamide activates peripheral nociceptors in normal and arthritic rat knee joints (full - 2001)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty
acid amide hydrolase (full - 2001)
http://www.ncbi.nlm.nih.gov/pmc/arti...7/?tool=pubmed
Endogenous cannabinoid anandamide increases heart resistance to arrhythmogenic effects of
epinephrine: role of CB(1) and CB(2) receptors.
(abst - 2001)
http://www.ncbi.nlm.nih.gov/sites/en...t=abstractplus
Quantification of anandamide content in animal cells and tissues: the normalization makes the
difference (full - 2002)
http://www.lipidworld.com/content/1/1/4
19. Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease (full -
2002)
http://bloodjournal.hematologylibrar...a7d081bcc2771d
A Peripheral Mechanism for CB1 Cannabinoid Receptor-Dependent Modulation of Feeding (full - 2002)
http://www.jneurosci.org/cgi/content...e2=tf_ipsecsha
Endogenous cannabinoids improve myocardial resistance to arrhythmogenic effects of coronary
occlusion and reperfusion: a possible mechanism.
(abst - 2002)
http://www.ncbi.nlm.nih.gov/sites/en...t=abstractplus
Role of Endogenous Cannabinoids in Synaptic Signaling (full - 2003)
http://physrev.physiology.org/cgi/co...urcetype=HWCIT
CB1 cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents
endothelial dysfunction and hypotension in rats with myocardial infarction (full - 2003)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral
lipogenesis (full - 2003)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC166293/
Endocannabinoids protect the rat isolated heart against ischaemia (full - 2003)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Cannabis and the brain. (full - 2003)
http://brain.oxfordjournals.org/cgi/...ull/126/6/1252
Chronic Morphine Modulates the Contents of the Endocannabinoid, 2-Arachidonoyl Glycerol, in Rat
Brain (full - 2003)
http://www.nature.com/npp/journal/v2.../1300117a.html
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis
(full - 2003)
http://brain.oxfordjournals.org/cgi/...a2614552989ba0
Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication
of epidermal growth factor receptor down-regulation and ceramide production. (abst - 2003)
http://www.ncbi.nlm.nih.gov/pubmed/1...?dopt=Abstract
Therapeutic potential of cannabinoids in CNS disease. (abst - 2003)
http://www.ncbi.nlm.nih.gov/pubmed/12617697
Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis
study. (abst - 2003)
http://www.ncbi.nlm.nih.gov/pubmed/1...?dopt=Abstract
20. The endocannabinoid system: a general view and latest additions
(full - 2004)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Endocannabinoids: Getting the message across (full - 2004)
http://www.pnas.org/content/101/23/8...urcetype=HWCIT
Endocannabinoids and Their Implications for Epilepsy (full - 2004)
http://www.pubmedcentral.nih.gov/art...tool=pmcentrez
The complexities of the cardiovascular actions of cannabinoids (full - 2004)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Anandamide Is Able to Inhibit Trigeminal Neurons Using an in Vivo Model of Trigeminovascular-
Mediated Nociception (full - 2004)
http://jpet.aspetjournals.org/content/309/1/56.full
Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed
vanilloid receptor-1 (full - 2004)
http://science.iowamedicalmarijuana....sot%202004.pdf
Up-Regulation of Cyclooxygenase-2 Expression Is Involved in R(_)-Methanandamide-Induced Apoptotic
Death of Human Neuroglioma Cells
(full - 2004)
http://science.iowamedicalmarijuana....inz%202004.pdf
Involvement of cannabinoid receptors in gut motility and visceral perception
(full - 2004)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Plasma Levels of the Endocannabinoid Anandamide in Women—A Potential Role in Pregnancy
Maintenance and Labor? (full - 2004)
http://jcem.endojournals.org/cgi/con...ed69b1d2e58a5b
Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes. (abst -
2004)
http://www.ncbi.nlm.nih.gov/pubmed/16574988
Cardiovascular Pharmacology of Cannabinoids (full - 2005)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
The cardiovascular actions of anandamide: more targets? (full - 2005)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Cannabinoids promote hippocampus neurogenesis and produce anxiolytic- and antidepressant-like
effects (full - 2005)
http://www.jci.org/cgi/content/full/115/11/3104
21. Blood pressure regulation by endocannabinoids and their receptors
(full - 2005)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible
role for cyclooxygenase 2 (full - 2005)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Antidepressant-like activity by blockade of anandamide hydrolysis (full - 2005)
http://www.pubmedcentral.nih.gov/art...medid=16352709
The effects of Δ9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the
endocannabinoid anandamide (full - 2005)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia–reperfusion by a novel
cannabinoid mechanism (full - 2005)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to
diet-induced obesity (full - 2005)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Analgesia through endogenous cannabinoids (analysis - 2005)
http://www.cmaj.ca/cgi/content/full/...urcetype=HWCIT
Anandamide Induced Anti-Convulsion in an In Vitro Model of Epilepsy
(abst - 2005)
http://www.kau.edu.sa/centers/spc/jk...ed/12/Mada.pdf
Influence of Anandamide, the Endogenous Agonist of Cannabinoid Receptors on the Circulatory System
(abst - 2005)
http://medical-journals.healia.com/d...ulatory-system
A biosynthetic pathway for anandamide (full - 2006)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557387/
Regulation, Function, and Dysregulation of Endocannabinoids in Models of Adipose and ß-Pancreatic
Cells and in Obesity and Hyperglycemia (full - 2006)
http://jcem.endojournals.org/cgi/con...eee8eb61349982
Stage-variations of anandamide hydrolase activity in the mouse uterus during the natural oestrus cycle
( full - 2006) (needs registration)
http://archive.biomedcentral.com/1743-1050/3/3
Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in
SOD1 mice (full - 2006)
http://www.fasebj.org/cgi/content/full/20/7/1003
22. Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection (full
- 2006)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated
excitotoxic damage (full - 2006)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Inhibition of Salivary Secretion by Activation of Cannabinoid Receptors
(full - 2006)
http://ebm.rsmjournals.com/cgi/conte...urcetype=HWCIT
Not Too Excited? Thank Your Endocannabinoids (full - 2006)
http://www.sciencedirect.com/science...3b7208dd2db26b
Effect of N-arachidonoyl-(2-methyl-4-hydroxyphenyl) amine (VDM11), an anandamide transporter
inhibitor, on capsaicin-induced cough in mice
(full - 2006)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Cannabinoids and the Endocannabinoid System (full - 2006) http://www.cannabis-
med.org/english/..._2006_01_2.pdf
Synthesis of a potential photoactivatable anandamide analog (abst - 2006)
http://www.sciencedirect.com/science...0e8211914e9559
Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-
inflammatory drug, in acute and inflammatory pain (abst - 2006)
http://www.sciencedirect.com/science...6267fd1a0650a4
Role of cannabinoid receptor agonists in mechanisms of suppression of central pain syndrome. (abst -
2006)
http://www.ncbi.nlm.nih.gov/sites/en...t=abstractplus
Anandamide inhibits adhesion and migration of breast cancer cells. (abst - 2006)
http://www.ncbi.nlm.nih.gov/pubmed/1...?dopt=Abstract
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury (full - 2007)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain (full -
2007)
http://www.ncbi.nlm.nih.gov/pmc/arti...4/?tool=pubmed
Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB1 and TRPV1
receptors (full - 2007)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
23. Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats (full - 2007)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Identification of Endocannabinoids and Related Compounds in Human Fat Cells
(full- 2007)
http://www.nature.com/oby/journal/v1...y2007100a.html
Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats (full -2007)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Endocannabinoids and the haematological system (full - 2007)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
The CB1 Cannabinoid Receptor Mediates Excitotoxicity-induced Neural Progenitor Proliferation and
Neurogenesis (full - 2007)
http://www.jbc.org/content/282/33/23892.full
Chronologically overlapping occurrences of nicotine-induced anxiety- and depression-related behavioral
symptoms: effects of anxiolytic and cannabinoid drugs (full - 2007)
http://www.biomedcentral.com/1471-2202/8/76
Involvement of the Endocannabinoid System in Retinal Damage after High Intraocular Pressure–Induced
Ischemia in Rats (full - 2007)
http://www.iovs.org/cgi/content/full...urcetype=HWCIT
Opposing Actions of Endocannabinoids on Cholangiocarcinoma Growth
(full - 2007)
http://www.jbc.org/content/282/17/13098.full
Endocannabinoids, cannabinoid receptors and inflammatory stress: an interview with Dr. Pál Pacher
(interview - 2007)
http://www.jleukbio.org/cgi/content/...urcetype=HWCIT
Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients
(abst - 2007)
http://www.unboundmedicine.com/medli...f_cannabis_use
Marijuana-Like Brain Chemicals Work As Antidepressant (news - 2007)
http://www.sciencedaily.com/releases...1105120556.htm
Role seen for cannabis in helping to alleviate allergic skin disease (news - 2007)
http://www.physorg.com/news106487623.html
CB1 Cannabinoid Receptor Inhibition: Promising Approach for Heart Failure?
(full - 2008)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
24. N-arachidonylethanolamide-Induced Increase in Aqueous Humor Outflow Facility (full - 2008)
http://www.iovs.org/cgi/content/full/49/10/4528
Pharmacological Inhibition of CB1 Cannabinoid Receptor Protects Against Doxorubicin-Induced
Cardiotoxicity (full - 2008)
http://content.onlinejacc.org/cgi/content/full/50/6/528
Modulation of the Endocannabinoid System in Cardiovascular Disease
(full - 2008)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats (full -
2008)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids:
Involvement of Regulatory T Cells (full - 2008)
http://molpharm.aspetjournals.org/co...#content-block
Cannabinoid receptors and the regulation of bone mass (full - 2008)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the
noncanonical Wnt signaling pathway (full - 2008)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Role of cannabinoids and endocannabinoids in cerebral ischemia
(full - 2008)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Endocannabinoid Dysregulation in the Pancreas and Adipose Tissue of Mice Fed With a High-fat Diet (full
- 2008)
http://www.nature.com/oby/journal/v1...y2007106a.html
Mechanisms for Recycling and Biosynthesis of Endogenous Cannabinoids Anandamide and 2-
Arachidonylglycerol (full - 2008)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
The endocannabinoid system: emotion, learning and addiction. (abst - 2008)
http://www.ncbi.nlm.nih.gov/pubmed/18422832
Anandamide and neutrophil function in patients with fibromyalgia. (abst - 2008)
http://www.ncbi.nlm.nih.gov/pubmed/18395993
Understanding the effects of endogenous cannabinoids (news - 2008)
http://arstechnica.com/science/news/...nnabinoids.ars
Marijuana-Inspired Painkiller? New Chemical Pathway Discovered
25. (news - 2008)
http://www.sciencedaily.com/releases...1123150249.htm
Endocannabinoids and the Heart (full - 2009)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation
(full - 2009)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Localisation and Function of the Endocannabinoid System in the Human Ovary
(full - 2009)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Changes in the Endocannabinoid System May Give Insight into new and Effective Treatments for Cancer
(full - 2009)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Biomarkers of Endocannabinoid System Activation in Severe Obesity
(full - 2009)
http://www.ncbi.nlm.nih.gov/pmc/arti...0/?tool=pubmed
Endocannabinoids and Their Receptors as Targets for Obesity Therapy
(full - 2009)
http://endo.endojournals.org/cgi/con...150/6/2531#top
Chapter 9 The Endocannabinoid Anandamide: From Immunomodulation to Neuroprotection.
Implications for Multiple Sclerosis (abst - 2009)
http://www.sciencedirect.com/science...f896233d3703f5
Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
(abst - 2009)
http://www.ncbi.nlm.nih.gov/pubmed/19502530
Is GPR55 an anandamide receptor? (abst - 2009)
http://www.ncbi.nlm.nih.gov/pubmed/19647110
A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines
by activation of apoptosis (abst - 2009)
http://www.unboundmedicine.com/medli..._of_apoptosis_
Differential alterations of the concentrations of endocannabinoids and related lipids in the
subcutaneous adipose tissue of obese diabetic patients (full - 2010)
http://www.lipidworld.com/content/9/1/43
Are You Cannabis Deficient? (news - 2010)
http://health.blogs.foxnews.com/2010...bis-deficient/
26. ANECDOTAL / PERSONAL STORIES
My Mother and Alzheimer’s (anecdotal - no date)
http://www.jackherer.com/mom.html
ANECDOTAL ARTICLES (anecdotal - no date)
http://cannabislink.ca/medical/#medanecdotal
ADHD by Ryan P (anecdotal - no date)
http://www.rxmarijuana.com/shared_comments/ADHD4.htm
Menière’s Syndrome by Charlie Ritchie (anecdotal - no date)
http://www.rxmarijuana.com/shared_comments/ritchie.htm
Chemotherapy for Testicular Cancer (anecdotal - no date)
http://www.rxmarihuana.com/shared_co...cularchemo.htm
Recipe For Trouble (news/anecdotal - 2002)
http://www.cbsnews.com/stories/2002/...in503022.shtml
Skin Complaint Man Grew Cannabis (news/ anecdotal- 2004)
http://www.mapinc.org/drugnews/v04.n1222.a09.html
Testimony of Mr. Rene Carlos Guevara to FDA (anecdotal - 2005)
http://www.fda.gov/ohrms/dockets/doc...N-0479-EC4.htm
Testimony of Terry Jacobs to FDA - why he prefers for medical marijuana to Marinol (news/anecdotal -
2005)
http://www.examiner.com/examiner/x-1...ana-to-Marinol
Cannabis Sativa (Marijuana) for Fibromyalgia (anecdotal - 2007 - 2010)
http://www.fibromyalgia-reviews.com/Drg_Marijuana.cfm
Shared Comments and Observations (anecdotal -2009)
http://www.rxmarihuana.com/comments_...servations.htm
Why I Give My 9-year-old Pot (news/ anecdotal - 2009)
http://www.doublex.com/section/healt...9-year-old-pot
Why I Give My 9-Year-Old Pot, Part II (news/anecdotal - 2009)
http://www.doublex.com/section/healt...ld-pot-part-ii
Julie Falco brings hope to Multiple Sclerosis patients. Cannabinoids manage pain and promote repair!
(news - 2010)
http://www.examiner.com/x-19678-Cann...promote-repair
The Cannabis Closet: Severe Eczema (anecdotal - 2010)
http://andrewsullivan.theatlantic.co...re-eczema.html
27. Cannabis and PTSD by Michael McKenna (anecdotal - 2010)
http://marijuana-uses.com/cannabis-a...chael-mckenna/
Weed Control Part 1: MS sufferer finds relief with medical marijuana
(anecdotal/news - 2010)
http://www.thestarphoenix.com/opinio...412/story.html
ANOREXIA NERVOSA - also see APPETITE STIMULANT
Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa
(full - 2008)
http://www.capmh.com/content/2/1/33
ANTI-BACTERIAL PROPERTIES
HEMP AS A MEDICAMENT : Methods and results of the bacteriological experiments (full - 1955)
http://www.greenpassion.org/showthre...750#post306750
Antibacterial preparation from hemp (Cannabis sativa) (abst - 1958)
http://chemport.cas.org/cgi-bin/sdcg...52c26c9bba3cd1
Hemp (Cannabis sativa)-an antibiotic drug. II. Methods and results of bacteriological investigations and
preliminary clinical experiences (abst -1958)
http://chemport.cas.org/cgi-bin/sdcg...2d1f297d624fc6
Effect of Biogenic Amines and Cannabinoids on Bacterial Chemotaxis
(full - 1973)
http://www.ncbi.nlm.nih.gov/pmc/arti...246374/?page=1
Antibacterial activity of delta9-tetrahydrocannabinol and cannabidiol.
(abst - 1976)
http://www.ncbi.nlm.nih.gov/sites/en...t=abstractplus
Susceptibility of Naegleria fowleri to delta 9-tetrahydrocannabinol. (full - 1979)
http://aac.asm.org/cgi/reprint/16/5/...urcetype=HWCIT
Biological activity of cannabichromene, its homologs and isomers. (abst - 1981)
http://www.ncbi.nlm.nih.gov/pubmed/7298870
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
(full - 2008)
http://www.cannabisasmedicine.com/st...activity-study
Pot is good for you? Marijuana fights the superbugs (news - 2008)
http://www.scientificamerican.com/bl...8-08-27&sc=rss
Killing bacteria with cannabis (news - 2008)
28. http://arstechnica.com/journals/scie...-with-cannabis
A New MRSA Defense (news - 2008)
http://www.technologyreview.com/biomedicine/21366/?a=f
Chemicals in Marijuana May Fight MRSA (news - 2008)
http://www.webmd.com/news/20080904/m...may-fight-mrsa
Cannabis Compounds Reduce Multi-Drug Resistant Infections (news - 2009)
http://www.medicalnewstoday.com/articles/147523.php
Biologically Active Cannabinoids from High-Potency Cannabis sativa.
(abst - 2009)
http://www.unboundmedicine.com/medli...nnabis_sativa_
Characterization and antimicrobial activity of essential oils of industrial hemp varieties (Cannabis sativa
L.). (abst - 2009)
http://www.ncbi.nlm.nih.gov/pubmed/19969046
Cannabis Compounds Reduce Multi-Drug Resistant Infections (news - 2009)
http://findarticles.com/p/articles/m...g=content;col1
Natural plant cannabinoids reduce multi-drug resistant infections (news - 2009)
http://www.news-medical.net/news/2009/04/23/48757.aspx
ANTI-FUNGAL PROPERTIES
Biologically Active Cannabinoids from High-Potency Cannabis sativa.
(abst - 2009)
http://www.unboundmedicine.com/medli...nnabis_sativa_
ANTI-INFLAMMATORY PROPERTIES
Biological activity of cannabichromene, its homologs and isomers. (abst - 1981)
http://www.ncbi.nlm.nih.gov/pubmed/7298870
Analgesic and antiinflammatory activity of constituents of Cannabis sativa L. (full - 1988)
http://www.ukcia.org/research/Analge...stituents.html
1′,1′-Dimethylheptyl-Δ-8-tetrahydrocannabinol-11-oic Acid: A Novel, Orally Effective Cannabinoid with
Analgesic and Anti-inflammatory Properties
(full - 1999)
http://jpet.aspetjournals.org/conten...urcetype=HWCIT
Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid
nabilone in a model of acute inflammation in the rat
(full - 2002)
http://www.pubmedcentral.nih.gov/art...tool=pmcentrez
29. Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model. (abst - 2003)
http://www.ncbi.nlm.nih.gov/pubmed/14644587
New perspectives in the studies on endocannabinoid and cannabis: 2-arachidonoylglycerol as a possible
novel mediator of inflammation
(full - 2004)
http://www.jstage.jst.go.jp/article/jphs/96/4/367/_pdf
Cannabinoids and neuroinflammation (full - 2004)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation.
(full - 2004)
http://ajpgi.physiology.org/cgi/content/full/287/1/G7
A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in
murine collagen-induced arthritis. (abst - 2004)
http://www.ncbi.nlm.nih.gov/pubmed/15022343
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
(full - 2005)
http://www.jneuroinflammation.com/content/2/1/29
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro:
relevance to Parkinson's disease. (abst - 2005)
http://www.ncbi.nlm.nih.gov/pubmed/1...?dopt=Abstract
Ajulemic acid (IP-751): Synthesis, proof of principle, toxicity studies, and clinical trials (abst - 2005)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of
Acute and Chronic Pain Episodes (full - 2006)
http://www.ncbi.nlm.nih.gov/pmc/arti...2/?tool=pubmed
Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by
attenuating oxidative stress, inflammatory response, and apoptosis (full - 2007)
http://www.jleukbio.org/cgi/content/full/82/6/1382
Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS
expression (Alzheimer's) (full - 2007)
http://www.pubmedcentral.nih.gov/art...tool=pmcentrez
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in
vitro (full - 2007)
http://www.pubmedcentral.nih.gov/art...tool=pmcentrez
Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain
30. inflammation (full - 2007)
http://www.pubmedcentral.nih.gov/art...tool=pmcentrez
Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model
of autoimmune uveoretinitis (full - 2007)
http://www.jleukbio.org/cgi/reprint/...urcetype=HWCIT
Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain (full -
2007)
http://www.ncbi.nlm.nih.gov/pmc/arti...4/?tool=pubmed
The endocannabinoid system in targeting inflammatory neurodegenerative diseases (full - 2007)
http://medicalcannabis.com/images/pd...tory_neuro.pdf
Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic
pain (full - 2007)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Endocannabinoids, cannabinoid receptors and inflammatory stress: an interview with Dr. Pál Pacher
(interview - 2007)
http://www.jleukbio.org/cgi/content/...urcetype=HWCIT
Cannabinoids for the treatment of inflammation. (abst - 2007)
http://www.ncbi.nlm.nih.gov/sites/en...t=abstractplus
Constituents Of Hashish And Marijuana May Help To Fight Inflammation And Allergies (news - 2007)
http://www.sciencedaily.com/releases...0607171120.htm
Endocannabinoids appear to play important role in regulating inflammation
(news - 2007)
http://www.news-medical.net/news/2007/06/08/26114.aspx
Marijuana Skin Cream? (news - 2007)
http://www.jointogether.org/news/res...kin-cream.html
Anti-inflammatory cannabinoids in diet (full - 2008)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Cannabinoid receptors in acute and chronic complications of atherosclerosis
(full - 2008)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Inflammation and aging: can endocannabinoids help? (full - 2008)
http://www.pubmedcentral.nih.gov/art...tool=pmcentrez
Cannabinoid CB2 receptors in human brain inflammation (full - 2008)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219537/
31. Cannabinoid Modulation of Cutaneous A{delta} Nociceptors During Inflammation (full - 2008)
http://jn.physiology.org/cgi/reprint/100/5/2794
Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders. (abst - 2008)
http://www.unboundmedicine.com/medli...CNS_disorders_
Why Cannabis Stems Inflammation (news - 2008)
http://www.sciencedaily.com/releases...0720222549.htm
Emerging Role of the CB2 Cannabinoid Receptor in Immune Regulation and Therapeutic Prospects (full -
2009)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic
Steatosis (full - 2009)
http://www.ncbi.nlm.nih.gov/pmc/arti...0/?tool=pubmed
Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-
inflammatory eicosanoid, lipoxin A4 (full - 2009)
http://www.fasebj.org/cgi/content/fu...urcetype=HWCIT
Cannabinoids as Therapeutic Agents for Ablating Neuroinflammatory Disease (full - 2009)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation
(full - 2009)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory
cytokines during experimental periodontitis in rats.
(abst - 2009)
http://www.unboundmedicine.com/medli...titis_in_rats_
ANTIOXIDANT PROPERTIES
Biological screening of 100 plant extracts for cosmetic use (II): anti-oxidative activity and free radical
scavenging activity. (abst - 1997)
http://www.unboundmedicine.com/medli...ging_activity_
Cannabidiol and (−)Δ9-tetrahydrocannabinol are neuroprotective antioxidants (full - 1998)
http://www.pubmedcentral.nih.gov/art...tool=pmcentrez
Cannabinoids protect cells from oxidative cell death: a receptor-independent mechanism. (full - 2000)
http://jpet.aspetjournals.org/content/293/3/807.full
US Patent 6630507 - Cannabinoids as antioxidants and neuroprotectants
(full - 2003)
http://www.patentstorm.us/patents/6630507.html
32. Synergistic Interactions between Cannabinoids and Environmental Stress in the Activation of the Central
Amygdala (full - 2005)
http://www.nature.com/npp/journal/v3.../1300535a.html
Protective effects of Δ9-tetrahydrocannabinol against N-methyl-D-aspartate-induced AF5 cell death (full
- 2005)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Repeated Treatment with Cannabidiol but Not Delta9-tetrahydrocannabinol Has a Neuroprotective
Effect Without the Development of Tolerance (abst - 2007)
http://medical-journals.healia.com/d...t-of-tolerance
Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders. (abst - 2008)
http://www.unboundmedicine.com/medli...CNS_disorders_
ANXIOLYTIC EFFECTS (anti- anxiety)
Sedative activity of cannabis in relation to its delta'-trans-tetrahydrocannabinol and cannabidiol content.
(full - 1981)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxiety (abst - 1981)
http://www.cannabis-med.org/studies/...ern=ANXIOLYTIC.
Single-dose study of nabilone in anxious volunteers. (abst - 1981)
http://www.cannabis-med.org/studies/...blood,pressure
Anxiety with Depression Research Review (full - 2000)
http://www.ukcia.org/research/Anxiet...archReview.pdf
Therapeutic aspects of cannabis and cannabinoids. (full - 2001)
http://bjp.rcpsych.org/cgi/content/full/178/2/107
Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters. (abst - 2001)
http://www.ncbi.nlm.nih.gov/pubmed/11566149
Marijuana's Distant Relative May Be The Next Prozac; Chemical Reduces Anxiety Using Novel Nerve
System In Body (news - 2002)
http://www.sciencedaily.com/releases...1202071928.htm
Marijuana Eyed for Treatment of Anxiety Disorders (news - 2004)
http://www.jointogether.org/news/res...treatment.html
Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and
antidepressant-like effects (full - 2005)
http://www.jci.org/cgi/content/full/115/11/3104
33. Enhancing Cannabinoid Neurotransmission Augments the Extinction of Conditioned Fear (full - 2005)
http://www.nature.com/npp/journal/v3.../1300655a.html
Cannabidiol as an antipsychotic. A double-blind, controlled clinical trial on cannabidiol vs. amisulpride in
acute schizophrenia. (abst - 2005)
http://www.cannabis-med.org/studies/...ern=ANXIOLYTIC
Endocannabinoids -- The Brain's Cannabis -- Demonstrate Novel Modes Of Action To Stress (news -
2005)
http://www.sciencedaily.com/releases...0720065810.htm
Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia
(full - 2006)
http://science.iowamedicalmarijuana....her%202006.pdf
Cannabinoid CB1 Receptor Mediates Fear Extinction via Habituation-Like Processes (full - 2006)
http://www.jneurosci.org/cgi/content...urcetype=HWCIT
Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug (full - 2006)
http://www.scielo.br/scielo.php?pid=...i_arttext#Text
Chronologically overlapping occurrences of nicotine-induced anxiety- and depression-related behavioral
symptoms: effects of anxiolytic and cannabinoid drugs (full - 2007) (needs registration)
http://www.biomedcentral.com/1471-2202/8/76
Modulation of Fear and Anxiety by the Endogenous Cannabinoid System
(full - 2007)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Chronologically overlapping occurrences of nicotine-induced anxiety- and depression-related behavioral
symptoms: effects of anxiolytic and cannabinoid drugs (full - 2007)
http://www.biomedcentral.com/1471-2202/8/76
Cannabinoid Modulation of Amygdala Reactivity to Social Signals of Threat in Humans (full - 2008)
http://www.jneurosci.org/cgi/content...urcetype=HWCIT
The association between anxiety and alcohol versus cannabis abuse disorders among adolescents in
primary care settings (full - 2008)
http://fampra.oxfordjournals.org/cgi.../full/25/5/321
Marijuana-Based Drug Reduces Fibromyalgia Pain, Study Suggests
(news - 2008)
http://www.sciencedaily.com/releases...0217214547.htm
Endocannabinoids: Stress, Anxiety, and Fear (full - 2009)
http://neuro.psychiatryonline.org/cg...urcetype=HWCIT
Effects of {Delta}9-tetrahydrocannabinol on reward and anxiety in rats exposed to chronic unpredictable
34. stress. (abst - 2009) http://www.unboundmedicine.com/medli...ctable_stress_
Modulation of effective connectivity during emotional processing by Delta9-tetrahydrocannabinol and
cannabidiol. (abst - 2009)
http://www.ncbi.nlm.nih.gov/pubmed/1...ubmed_RVDocSum
Opposite Effects of Delta-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and
Psychopathology. (abst - 2009)
http://www.unboundmedicine.com/medli...ychopathology_
APPETITE STIMULANT
Factors influencing the aggressiveness elicited by marihuana in food-deprived rats (full - 1972)
http://www.pubmedcentral.nih.gov/art...tool=pmcentrez
Behavioral analysis of marijuana effects on food intake in humans. (abst - 1986)
http://www.cannabis-med.org/studies/...w.php?s_id=118
Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory.
(abst - 1988)
http://www.cannabis-med.org/studies/...w.php?s_id=117
Dronabinol enhancement of appetite in cancer patients. (abst - 1990)
http://www.cannabis-med.org/studies/...w.php?s_id=149
Recent clinical experience with dronabinol. (abst - 1991)
http://www.cannabis-med.org/studies/...ow.php?s_id=90
Dronabinol stimulates appetite and causes weight gain in HIV patients.
(abst - 1992)
http://www.cannabis-med.org/studies/...ow.php?s_id=20
Dronabinol effects on weight in patients with HIV infection. (abst - 1992)
http://www.cannabis-med.org/studies/...ow.php?s_id=45
Effect of dronabinol on nutritional status in HIV infection. (abst - 1993)
http://www.cannabis-med.org/studies/...w.php?s_id=150
A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia.
(abst - 1994)
http://www.cannabis-med.org/studies/...ow.php?s_id=52
Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. (abst - 1995)
http://www.cannabis-med.org/studies/...ow.php?s_id=21
The perceived effects of smoked cannabis on patients with multiple sclerosis. (abst - 1997)
http://www.cannabis-med.org/studies/...ow.php?s_id=13
35. Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease (abst -
1997)
http://www.cannabis-med.org/studies/...ow.php?s_id=59
Immunoactive cannabinoids: Therapeutic prospects for marijuana constituents
(full - 2000)
http://www.pubmedcentral.nih.gov/art...tool=pmcentrez
Therapeutic Aspects of Cannabis and Cannabinoids (full - 2001)
http://bjp.rcpsych.org/cgi/reprint/178/2/107.pdf
Neuroprotection by Delta 9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against
Ouabain-Induced In Vivo Excitotoxicity
(full - 2001)
http://www.jneurosci.org/cgi/content...urcetype=HWCIT
Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats (full - 2001)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Attack of the munchies (news - 2001)
http://www.newscientist.com/article/...-munchies.html
A Peripheral Mechanism for CB1 Cannabinoid Receptor-Dependent Modulation of Feeding (full - 2002)
http://www.jneurosci.org/cgi/content...e2=tf_ipsecsha
The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral
lipogenesis (full - 2003)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC166293/
Endogenous cannabinoid system as a modulator of food intake.
(full - 2003)
http://www.nature.com/ijo/journal/v2.../0802250a.html
Safety and efficacy of dronabinol in the treatment of agitation in patients with Alzheimer’s disease with
anorexia: A retrospective chart review (abst - 2003)
http://www.cannabis-med.org/studies/...ow.php?s_id=61
Endocannabinoids: Getting the message across (full - 2004)
http://www.pnas.org/content/101/23/8...urcetype=HWCIT
Endocannabinoids and food intake: newborn suckling and appetite regulation in adulthood. (full - 2005)
http://ebm.rsmjournals.com/cgi/content/full/230/4/225
Food for thought: endocannabinoid modulation of lipogenesis (full - 2005)
http://www.jci.org/articles/view/25076/version/1
Endocannabinoids in the Regulation of Appetite and Body Weight. (abst - 2005)
http://medical-journals.healia.com/d...nd-body-weight
36. THC effective in appetite and weight loss in severe lung disease (COPD)
(news - 2005)
http://www.cannabis-med.org/english/...l.php?id=191#2
Machinery Of The 'Marijuana Munchies' (news - 2005)
http://www.sciencedaily.com/releases...1226102503.htm
Cancer-related anorexia-cachexia syndrome (abst - 2006)
http://www.unboundmedicine.com/medli...ia_Study_Group
The synthetic cannabinoid nabilone improves pain and symptom management in cancer patients (abst -
2006)
http://www.cannabis-med.org/studies/...w.php?s_id=177
Dronabinol for supportive therapy in patients with malignant melanoma and liver metastases (abst -
2006)
http://www.cannabis-med.org/studies/...w.php?s_id=180
Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human
subjects: a randomized, placebo-controlled study
(abst - 2006)
http://cel.isiknowledge.com/InboundS...ersID=Highwire
CANNABINOID-INDUCED HYPERPHAGIA: CORRELATION WITH INHIBITION OF PROOPIOMELANOCORTIN
NEURONS? (full - 2007)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
The endogenous cannabinoid system: a new player in the brain-gut-adipose axis
(full - 2007)
http://www.cannabis-med.org/english/..._2007_02_1.pdf
Dronabinol an effective appetite stimulant? (abst - 2007)
http://www.cannabis-med.org/studies/...w.php?s_id=188
THC improves appetite and reverses weight loss in AIDS patients (abst - 2007)
http://www.cannabis-med.org/studies/...w.php?s_id=189
Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed
chemotherapy-induced nausea and vomiting.
(abst - 2007)
http://www.cannabis-med.org/studies/...w.php?s_id=191
Dronabinol and marijuana in HIV-positive marijuana smokers: caloric intake, mood, and sleep. (abst -
2007)
http://www.cannabis-med.org/studies/...w.php?s_id=190
Feeding induced by cannabinoids is mediated independently of the melanocortin system. (full - 2008)
37. http://www.ncbi.nlm.nih.gov/pmc/arti...0/?tool=pubmed
Activating Parabrachial Cannabinoid CB1 Receptors Selectively Stimulates Feeding of Palatable Foods in
Rats (full - 2008)
http://www.jneurosci.org/cgi/content...urcetype=HWCIT
ENDOCANNABINOIDS AND THE NEUROCHEMISTRY OF GLUTTONY. (abst - 2008)
http://www.ncbi.nlm.nih.gov/pubmed/18638022
Endocannabinoids and Their Receptors as Targets for Obesity Therapy
(full - 2009)
http://endo.endojournals.org/cgi/con...150/6/2531#top
Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and
non-fasted mice (full - 2009)
http://www.ncbi.nlm.nih.gov/pmc/arti...5/?tool=pubmed
Endocannabinoids selectively enhance sweet taste (full - 2009)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Natural Pot-Like Compound Could Fight Obesity (news - 2009)
http://www.scientificamerican.com/po...d-fig-09-12-29
Enhanced Sweet Taste: Endocannabinoids Act Directly on Tongue Taste Receptors (news - 2009)
http://www.sciencedaily.com/releases...1222104920.htm
The multiple functions of the endocannabinoid system: a focus on the regulation of food intake. (full -
2010)
http://www.ncbi.nlm.nih.gov/pmc/arti...3/?tool=pubmed
Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their
Chosen Cannabis (abst - 2010)
http://www.nature.com/npp/journal/va...pp201058a.html
ARACHIDONYL-2'-CHLOROETHYLAMIDE / ACEA
Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids:
Involvement of Regulatory T Cells (full - 2008)
http://molpharm.aspetjournals.org/co...#content-block
2-ARACHIDONOYLGLYCEROL / 2-AG - an endocannabinoid, CB1
Brain Chemicals Mimic Marijuana (news - 1997)
http://www.ukcia.org/research/anandami.php
Endocannabinoids control spasticity in a multiple sclerosis model (full - 2000)
http://www.fasebj.org/cgi/reprint/00...urcetype=HWCIT
38. Endocannabinoids and Vascular Function (full - 2000)
http://jpet.aspetjournals.org/content/294/1/27.long
Cardiovascular effects of endocannabinoids--the plot thickens. (abst - 2000)
http://www.ncbi.nlm.nih.gov/sites/en...t=abstractplus
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction (full - 2001)
http://content.onlinejacc.org/cgi/co...urcetype=HWCIT
Inhibition of Rat C6 Glioma Cell Proliferation by Endogenous and Synthetic
Cannabinoids. Relative Involvement of Cannabinoid and Vanilloid Receptors
(full - 2001)
http://jpet.aspetjournals.org/content/299/3/951.full
Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of
intestinal inflammation (full - 2001)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor (full - 2001)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC31108/
An endogenous cannabinoid (2-AG) is neuroprotective after brain injury.
(abst - 2001)
http://www.ncbi.nlm.nih.gov/pubmed/11586361
Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune
cells (full - 2002)
http://www.fasebj.org/cgi/content/fu...urcetype=HWCIT
Endocannabinoids protect the rat isolated heart against ischaemia (full - 2003)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Chronic Morphine Modulates the Contents of the Endocannabinoid, 2-Arachidonoyl Glycerol, in Rat
Brain (full - 2003)
http://www.nature.com/npp/journal/v2.../1300117a.html
Role of Endogenous Cannabinoids in Synaptic Signaling (full - 2003)
http://physrev.physiology.org/cgi/co...urcetype=HWCIT
The Endogenous Cannabinoid System Regulates Seizure Frequency and Duration in a Model of Temporal
Lobe Epilepsy (full - 2003)
http://jpet.aspetjournals.org/conten...urcetype=HWCIT
The endocannabinoid system: a general view and latest additions
(full - 2004)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
New perspectives in the studies on endocannabinoid and cannabis: 2-arachidonoylglycerol as a possible
39. novel mediator of inflammation
(full - 2004)
http://www.jstage.jst.go.jp/article/jphs/96/4/367/_pdf
2-Arachidonoylglycerol A Novel Inhibitor of Androgen-Independent Prostate Cancer Cell Invasion (full -
2004)
http://cancerres.aacrjournals.org/cg...3a5a31aaf2b094
The endocannabinoid-CB receptor system: Importance for development and in pediatric disease. (abst -
2004)
http://www.ncbi.nlm.nih.gov/pubmed/15159678
CB1 cannabinoid receptor-mediated modulation of food intake in mice
(full - 2005)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Analgesia through endogenous cannabinoids (analysis - 2005)
http://www.cmaj.ca/cgi/content/full/...urcetype=HWCIT
The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA
expression of proinflammatory cytokines. (abst - 2005)
http://lib.bioinfo.pl/pmid:16364651
Body's Own Marijuana-Like Compounds Are Crucial For Stress-Induced Pain Relief (news - 2005)
http://www.sciencedaily.com/releases...0628064435.htm
Regulation, Function, and Dysregulation of Endocannabinoids in Models of Adipose and ß-Pancreatic
Cells and in Obesity and Hyperglycemia (full - 2006)
http://jcem.endojournals.org/cgi/con...eee8eb61349982
Not Too Excited? Thank Your Endocannabinoids (full - 2006)
http://www.sciencedirect.com/science...3b7208dd2db26b
Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection (full
- 2006)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Weight Control in Individuals With Diabetes (full - 2006)
http://care.diabetesjournals.org/con...urcetype=HWCIT
Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid
receptor ligand. (abst - 2006)
http://www.ncbi.nlm.nih.gov/pubmed/16678907
The CB1 Cannabinoid Receptor Mediates Excitotoxicity-induced Neural Progenitor Proliferation and
Neurogenesis (full - 2007)
http://www.jbc.org/content/282/33/23892.full
40. Endocannabinoids and the haematological system (full - 2007)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon
(full - 2007)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury (full - 2007)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Identification of Endocannabinoids and Related Compounds in Human Fat Cells
(full- 2007)
http://www.nature.com/oby/journal/v1...y2007100a.html
Endocannabinoids block status epilepticus in cultured hippocampal neurons
(full - 2007)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
CB2 receptors in the brain: role in central immune function (full - 2007)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Opposing Actions of Endocannabinoids on Cholangiocarcinoma Growth
(full - 2007)
http://www.jbc.org/content/282/17/13098.full
Chronologically overlapping occurrences of nicotine-induced anxiety- and depression-related behavioral
symptoms: effects of anxiolytic and cannabinoid drugs (full - 2007)
http://www.biomedcentral.com/1471-2202/8/76
Endocannabinoids, cannabinoid receptors and inflammatory stress: an interview with Dr. Pál Pacher
(interview - 2007)
http://www.jleukbio.org/cgi/content/...urcetype=HWCIT
The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling. (full - 2008)
http://www.fasebj.org/cgi/content/full/22/1/285
Cannabinoids Inhibit HIV-1 Gp120-Mediated Insults in Brain Microvascular Endothelial Cells (full - 2008)
http://www.jimmunol.org/cgi/content/...urcetype=HWCIT
Cannabinoid receptors and the regulation of bone mass (full - 2008)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Pharmacological Inhibition of CB1 Cannabinoid Receptor Protects Against Doxorubicin-Induced
Cardiotoxicity (full - 2008)
http://content.onlinejacc.org/cgi/content/full/50/6/528
Endocannabinoid Dysregulation in the Pancreas and Adipose Tissue of Mice Fed With a High-fat Diet (full
- 2008)
41. http://www.nature.com/oby/journal/v1...y2007106a.html
Activating Parabrachial Cannabinoid CB1 Receptors Selectively Stimulates Feeding of Palatable Foods in
Rats (full - 2008)
http://www.jneurosci.org/cgi/content...urcetype=HWCIT
Mechanisms for Recycling and Biosynthesis of Endogenous Cannabinoids Anandamide and 2-
Arachidonylglycerol (full - 2008)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Understanding the effects of endogenouscannabinoids (news - 2008)
http://arstechnica.com/science/news/...nnabinoids.ars
Marijuana-Inspired Painkiller? New Chemical Pathway Discovered
(news - 2008)
http://www.sciencedaily.com/releases...1123150249.htm
Changes in the Endocannabinoid System May Give Insight into new and Effective Treatments for Cancer
(full - 2009)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Endocannabinoids and Their Receptors as Targets for Obesity Therapy
(full - 2009)
http://endo.endojournals.org/cgi/con...150/6/2531#top
Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
(abst - 2009)
http://www.ncbi.nlm.nih.gov/pubmed/19502530
Differential alterations of the concentrations of endocannabinoids and related lipids in the
subcutaneous adipose tissue of obese d
iabetic patients (full - 2010)
http://www.lipidworld.com/content/9/1/43
The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after
spinal cord injury. (abst - 2010)
http://www.ncbi.nlm.nih.gov/pubmed/20156559
ARTHRITIS
ANTI-EDEMA AND ANALGESIC PROPERTIES OF Δ9-TETRAHYDROCANNABINOL (THC) (abst- 1973)
http://jpet.aspetjournals.org/conten...urcetype=HWCIT
Analgesic and antiinflammatory activity of constituents of Cannabis sativa L.
(full - 1988)
http://www.ukcia.org/research/Analge...stituents.html
US Patent 6132762 - Transcutaneous application of marijuana (full - 2000)
42. http://www.patentstorm.us/patents/6132762/fulltext.html
Immunoactive cannabinoids: Therapeutic prospects for marijuana constituents
(full - 2000) http://www.pubmedcentral.nih.gov/art...tool=pmcentrez
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine
collagen-induced arthritis (full - 2000)
http://www.ncbi.nlm.nih.gov/pmc/arti...4/?tool=pubmed
Marijuana Extract Helps Arthritis Pain (news - 2000)
http://www.prohealth.com//library/sh....cfm?libid=552
Anandamide activates peripheral nociceptors in normal and arthritic rat knee joints (full - 2001)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model. (abst - 2003)
http://www.ncbi.nlm.nih.gov/pubmed/14644587
Cannabis May Suppress Immune System (news - 2003)
http://lupus.webmd.com/news/20030415...-immune-system
A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in
murine collagen-induced arthritis. (abst - 2004)
http://www.ncbi.nlm.nih.gov/pubmed/15022343
Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in
the treatment of pain caused by rheumatoid arthritis
(full - 2005)
http://rheumatology.oxfordjournals.o...t/full/45/1/50
Ajulemic acid (IP-751): Synthesis, proof of principle, toxicity studies, and clinical trials (abst - 2005)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Rheumatoid arthritis, Cannabis based medicine eases pain and suppresses disease
(news - 2005)
http://www.medicalnewstoday.com/articles/33376.php
Cannabis-Based Drug Relieves Arthritis Pain (news - 2005)
http://www.medpagetoday.com/Rheumatology/Arthritis/2097
First study to use a cannabis-based medicine for treating rheumatoid arthritis (news - 2005)
http://www.news-medical.net/news/2005/11/09/14393.aspx
Pot-Based Drug Promising for Arthritis (news - 2005)
http://www.webmd.com/rheumatoid-arth...-for-arthritis
Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in
the treatment of pain caused by rheumatoid arthritis
43. (full - 2006)
http://rheumatology.oxfordjournals.o...urcetype=HWCIT
The use of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis
(letter - 2006)
http://rheumatology.oxfordjournals.o.../full/45/6/781
The Cannabinergic System as a Target for Anti-inflammatory Therapies
(abst - 2006)
http://www.ingentaconnect.com/conten...00013/art00008
SAFETY AND TOLERABILITY OF LONG-TERM TREATMENT WITH A CANNABIS-BASED MEDICINE (SATIVEX)
IN PATIENTS WITH RHEUMATOID ARTHRITIS (abst - 2006)
http://eular.bmj.com/cgi/content/abs...urcetype=HWCIT
In vivo effects of CB2 receptor-selective cannabinoids on the vasculature of normal and arthritic rat knee
joints (full - 2007)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
INHIBITORY EFFECT OF CANNABINOID AGONISTS ON CYTOKINE PRODUCTION IN HUMAN
OSTEOARTRITHIC AND RHEUMATOID FIBROBLAST-LIKE SYNOVIOCYTES (abst - 2007)
http://eular.bmj.com/cgi/content/abs...urcetype=HWCIT
Suppression of fibroblast metalloproteinases by ajulemic acid, a nonpsychoactive cannabinoid acid.
(abst - 2007)
http://www.ncbi.nlm.nih.gov/pubmed/16927387
The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat involves the CB(2)
cannabinoid receptor. (abst - 2007)
http://www.unboundmedicine.com/medli...inoid_receptor
Synergy between Delta(9)-tetrahydrocannabinol and morphine in the arthritic rat
(abst - 2007)
http://www.unboundmedicine.com/medli..._arthritic_rat
Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with
osteoarthritis and rheumatoid arthritis. (full - 2008)
http://www.ncbi.nlm.nih.gov/pmc/arti...2/?tool=pubmed
In vivo effects of CB2 receptor-selective cannabinoids on the vasculature of normal and arthritic rat knee
joints (full - 2008)
http://www.pubmedcentral.nih.gov/art...tool=pmcentrez
How Cannabis Compares to other aging treatments (article - 2008)
http://www.medical-marijuana-testimo...ijuana.htm#top
Arthritis and Cannabis (article - 2008)
http://www.medical-marijuana-testimo...-marijuana.htm
44. Suppression of human macrophage interleukin-6 by a nonpsychoactive cannabinoid acid. (abst - 2008)
http://www.ncbi.nlm.nih.gov/sites/pubmed
Ajulemic acid, a nonpsychoactive cannabinoid acid, suppresses osteoclastogenesis in mononuclear
precursor cells and induces apoptosis in mature osteoclast-like cells. (abst - 2008)
http://www.ncbi.nlm.nih.gov/pubmed/17786950
Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-
inflammatory eicosanoid, lipoxin A4 (full - 2009)
http://www.fasebj.org/cgi/content/fu...urcetype=HWCIT
Anti-inflammatory compound from cannabis found in herbs (news - 2008)
http://www.rsc.org/chemistryworld/Ne...e/24060801.asp
Cannabis offers hope to arthritis sufferers (news - 2009)
http://findarticles.com/p/articles/m...g=content;col1
ASTHMA
Acute effects of smoked marijuana and oral delta-9-tetrahydrocannabinol on specific airway
conductance in asthmatic subjects (full - 1974)
http://www.ukcia.org/research/Smoked...nAsthmatic.php
Effects of smoked marijuana in experimentally induced asthma. (full - 1975)
http://www.ukcia.org/research/InducedAsthma/index.php
Bronchodilator effect of delta1-tetrahydrocannabinol administered by aerosol of asthmatic patients.
(full - 1976)
http://www.ncbi.nlm.nih.gov/pmc/arti...centrez&page=1
Bronchial effects of aerosolized delta 9-tetrahydrocannabinol (abst - 1977)
http://www.cannabis-med.org/studies/...w.php?s_id=109
Bronchodilator effect of delta1-tetrahydrocannabinol. (full - 1978)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1429361/
Comparison of bronchial effects of nabilone and terbutaline (abst - 1983)
http://www.cannabis-med.org/studies/...ow.php?s_id=43
Acute and subacute bronchial effects of oral cannabinoids. (abst - 1984)
http://www.cannabis-med.org/studies/...ow.php?s_id=44
ANALGESIC AND ANTIINFLAMMATORY ACTIVITY OF CONSTITUENTS OF CANNABIS SATIVA L. (full - 1988)
http://www.ukcia.org/research/Analge...stituents.html
Therapeutic aspects of cannabis and cannabinoids. (full - 2001)
http://bjp.rcpsych.org/cgi/content/full/178/2/107
45. New Synthetic Delta-9-THC Inhaler Offers Safe, Rapid Delivery (news - 2005)
http://www.medicalnewstoday.com/articles/22937.php
The Cannabinergic System as a Target for Anti-inflammatory Therapies
(abst - 2006)
http://www.ingentaconnect.com/conten...00013/art00008
Cannabinoid CB2 receptor activation prevents bronchoconstriction and airway oedema in a model of
gastro-oesophageal reflux (abst - 2007)
http://www.sciencedirect.com/science...e5dbd08aee590f
ATHEROSCLEROSIS
Cardiovascular Effects of Cannabis (news - no date)
http://www.idmu.co.uk/canncardio.htm
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. (full - 2005)
http://www.nature.com/nature/journal...ture03389.html
Cannabis compound tackles blood vessel disease (news - 2005)
http://www.medicalnewstoday.com/articles/22658.php
Medical marijuana: study shows that THC slows atherosclerosis (news - 2005)
http://thenexthurrah.typepad.com/the...l_marijua.html
Science: THC slows development of atherosclerosis in animal study
(news - 2005)
http://www.cannabis-med.org/english/...l.php?id=190#1
Cannabis may help keep arteries clear (news - 2005)
http://www.newscientist.com/article/mg18624956.000
NOT SO DOPEY (news - 2005)
http://www.entheology.org/edoto/anmviewer.asp?a=221
Marijuana Chemical Fights Hardened Arteries (news - 2005)
http://www.webmd.com/heart-disease/n...dened-arteries
Does Cannabis Hold the Key to Treating Cardiometabolic Disease (needs free registration) (full - 2006)
http://www.medscape.com/viewarticle/525040_print
The Cannabinergic System as a Target for Anti-inflammatory Therapies
(abst - 2006)
http://www.ingentaconnect.com/conten...00013/art00008
Endocannabinoids and the haematological system (full - 2007)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
46. Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier
disruption (full - 2007)
http://www.pubmedcentral.nih.gov/art...tool=pmcentrez
Cannabinoid receptors in acute and chronic complications of atherosclerosis
(full - 2008)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Cholesterol-induced stimulation of platelet aggregation is prevented by a hempseed-enriched diet. (abst
- 2008)
http://www.ncbi.nlm.nih.gov/pubmed/18418423
The emerging role of the endocannabinoid system in cardiovascular disease
(full - 2009)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Endocannabinoids and the Heart (full - 2009)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Cannabidiol-2',6'-Dimethyl Ether, a Cannabidiol Derivative, Is a Highly Potent and Selective 15-
Lipoxygenase Inhibitor. (abst - 2009)
http://www.unboundmedicine.com/medli...ase_Inhibitor_
Cannabinoids and atherosclerosis. (abst - 2009)
http://www.unboundmedicine.com/medli...herosclerosis_
AUTISM
THE SAM PROJECT: James D. (news / anecdotal - 2002)
http://www.letfreedomgrow.com/articles/james_d.htm
Medical marijuana: a valuable treatment for autism? (news / anecdotal - 2003)
http://www.autism.com/ari/editorials/ed_marijuana.htm
Autism and Medical Marijuana (news / anecdotal - 2008?)
http://autism.com/treatable/drug/marijuana_org.htm
Autism, ADD, ADHD and Marijuana Therapy (news - 2008)
http://www.entheology.org/edoto/anmviewer.asp?a=319
Sam’s Story: Using Medical Cannabis to Treat Autism Spectrum Disorder
(news / anecdotal - 2009)
http://www.letfreedomgrow.com/cmu/SamsStory.htm
Mom: Medical marijuana saved son's life (news / anecdotal - 2009)
http://abclocal.go.com/kabc/story?se...lth&id=6989085
47. Sam's Story: Medical Marijuana and Autism (news / anecdotal - 2009)
http://www.ktla.com/news/landing/ktl...,1396115.story
BACK PAIN
BACK PAIN DUE TO DEGENERATED DISC –ANY THERAPEUTIC ROLE OF CANNABIS (abst - 2005)
http://proceedings.jbjs.org.uk/cgi/c...urcetype=HWCIT
BETA-CARYOPHYLENE/ (E)-BCP
Beta-caryophyllene is a dietary cannabinoid (full - 2008)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Anti-inflammatory cannabinoids in diet (full - 2008)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation
(full - 2009)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Screening for Antiviral Activities of Isolated Compounds from Essential Oils
(full - 2009)
http://ecam.oxfordjournals.org/cgi/c...urcetype=HWCIT
BIPOLAR DISORDER
The Use of Cannabis as a Mood Stabilizer in Bipolar Disorder: Anecdotal Evidence and the Need for
Clinical Research (full -1998)
http://www.ukcia.org/research/TheUse...rDisorder.html
Recipe For Trouble (anecdotal/ news - 2002 )
http://www.cbsnews.com/stories/2002/...in503022.shtml
Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential. (full -
2005)
http://www.ukcia.org/research/Cannab...veDisorder.pdf
Cannabis in bipolar (abst - 2005)
http://www.pendulum.org/bpnews/archive/001628.html
Cannabis Spray for Bipolar (news - 2005)
http://www.prohealth.com/me-cfs/blog....cfm?id=565511
Marijuana Could Provide Mental Health Treatments (news - 2005)
http://www.jointogether.org/news/res...d-provide.html
Chemicals in Cannabis may help mentally ill (news - 2005)
http://www.news-medical.net/news/2005/06/06/10716.aspx
48. The effect of extreme marijuana use on the long-term course of bipolar I illness: a single case study.
(abst - 2007)
http://www.cannabis-med.org/studies/...w.php?s_id=247
Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and
schizophrenia. (abst - 2009)
http://www.unboundmedicine.com/medli...schizophrenia_
BLADDER OVERACTIVITY/ INCONTINENCE
Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues
isolated from rat, mouse, pig, dog, monkey and human
(full - 2000)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Clinical investigation of delta-9-tetrahydrocannabinol (THC) as an alternative therapy for overactive
bladders in spinal cord injury (SCI) patients.
(abst - 2001)
http://www.cannabis-med.org/studies/...w.php?s_id=102
An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple
sclerosis. (full - 2004)
http://www.ukcia.org/research/CBEFor...ysfunction.pdf
Therapy Insight: Bladder Dysfunction Associated With Multiple Sclerosis
(full - 2005)
http://www.medscape.com/viewarticle/515091
Marijuana-Derived Drug Suppresses Bladder Overactivity And Irritation In Animal Models (news - 2005)
http://www.sciencedaily.com/releases...0906080225.htm
Marijuana-Derived Drug Suppresses Bladder Pain In Animal Models
(news - 2006)
http://www.sciencedaily.com/releases...0521103039.htm
Effects of IP-751, ajulemic acid, on bladder overactivity induced by bladder irritation in rats. (abst - 2007)
http://www.ncbi.nlm.nih.gov/pubmed/17656248
Cannabinoid receptor 2 is increased in acutely and chronically inflamed bladder of rats (full - 2008)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Distribution and function of cannabinoid receptors 1 and 2 in the rat, monkey and human bladder. (abst
- 2009)
http://www.ncbi.nlm.nih.gov/pubmed/19237169
Incontinence (news - 2009)
http://www.norml.org/index.cfm?Group_ID=7012
49. Functional role of cannabinoid receptors in urinary bladder (full - 2010)
http://www.indianjurol.com/article.a...5;aulast=Tyagi
BLOOD
The inhibitory effects of cannabinoids, the active constituents of Cannabis sativa L. on human and rabbit
platelet aggregation. (abst - 1989)
http://www.ncbi.nlm.nih.gov/pubmed/2575149
The Procoagulatory Effects of Delta-9-Tetrahydrocannabinol in Human Platelets
(full - 2004)
http://www.anesthesia-analgesia.org/...urcetype=HWCIT
Plasma Levels of the Endocannabinoid Anandamide in Women—A Potential Role in Pregnancy
Maintenance and Labor? (full - 2004)
http://jcem.endojournals.org/cgi/con...ed69b1d2e58a5b
Anticoagulant Effects of a Cannabis Extract in an Obese Rat Model (abst - 2007)
http://marijuana.researchtoday.net/archive/4/4/736.htm
BLOOD PRESSURE
Reduction by Δ9-tetrahydrocannabinol in the blood pressure of hypertensive rats bearing regenerated
adrenal glands (full - 1973)
http://www.ncbi.nlm.nih.gov/pmc/arti...776093/?page=1
Cannabinoids. II. Cardiovascular Effects (full - 1980)
http://jpet.aspetjournals.org/conten...e2=tf_ipsecsha
Effect of marihuana on intraocular and blood pressure in glaucoma (full - 1980)
http://www.ukcia.org/research/Effect...InGlaucoma.php
Glaucoma, hypertension, and marijuana. (full - 1982)
http://www.ncbi.nlm.nih.gov/pmc/arti...centrez&page=1
Anandamide and delta 9-THC dilation of cerebral arterioles is blocked by indomethacin (abst - 1995)
http://ajpheart.physiology.org/cgi/c...urcetype=HWCIT
Cannabinoid-Induced Hypotension and Bradycardia in Rats Is Mediated by CB1-Like Cannabinoid
Receptors (full - 1997)
http://jpet.aspetjournals.org/conten...urcetype=HWCIT
Body's 'cannabis' could hold blood pressure key (news - 1998)
http://www.ukcia.org/research/blood-pressure.php
Endocannabinoids and Vascular Function (full - 2000)
http://jpet.aspetjournals.org/content/294/1/27.long
50. Endogenous cannabinoids mediate hypotension after experimental myocardial infarction (full - 2001)
http://content.onlinejacc.org/cgi/co...urcetype=HWCIT
Cardiovascular Effects of Cannabis (news- 2003?)
http://www.idmu.co.uk/canncardio.htm
Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension
(full - 2004)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Blood pressure regulation by endocannabinoids and their receptors
(full - 2005)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Cardiovascular Pharmacology of Cannabinoids (full - 2005)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Influence of Anandamide, the Endogenous Agonist of Cannabinoid Receptors on the Circulatory System
(abst - 2005)
http://medical-journals.healia.com/d...ulatory-system
Further Characterization of the Time-Dependent Vascular Effects of Δ9-Tetrahydrocannabinol (full -
2006)
http://jpet.aspetjournals.org/content/317/1/428.full
Lowering Of Blood Pressure Achieved Through Use Of Hashish-Like Drug
(news - 2006)
http://www.sciencedaily.com/releases...0620083025.htm
Cannabis to lower blood pressure! (news - 2006)
http://www.news-medical.net/news/2006/06/19/18517.aspx
The in vitro and in vivo cardiovascular effects of {Delta}9-tetrahydrocannabinol (THC) in rats made
hypertensive by chronic inhibition of nitric oxide synthase.
(full - 2007)
http://jpet.aspetjournals.org/content/321/2/663.full
Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats (full - 2007)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats (full -
2008)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Modulation of the Endocannabinoid System in Cardiovascular Disease
(full - 2008)
http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
51. Endocannabinoids, blood pressure and the human heart. (full - 2008).
http://www3.interscience.wiley.com/c...9853/HTMLSTART
BONES - see OSTEOPOROSIS
BRAIN CELLS - see NEURONS
BRAIN - PHYSICAL EFFECTS
Chronic Exposure to Delta 9-tetrahydrocannabinol Fails to Irreversibly Alter Brain Cannabinoid
Receptors. (abst - 1991)
http://medical-journals.healia.com/d...noid-receptors
Effects of frequent marijuana use on brain tissue volume and composition
(abst - 1999)
http://www.ukcia.org/research/Effect...omposition.htm
Cannabinoid Receptor Messenger Rna Levels Decrease in a Subset of Neurons of the Lateral Striatum,
Cortex and Hippocampus of Transgenic Huntington's Disease Mice. (abst - 2000)
http://medical-journals.healia.com/d...s-disease-mice
Frequent Marijuana Use May Affect Brain Function But Not Structure
(news - 2000)
http://www.sciencedaily.com/releases...0331090541.htm
Cannabis and the brain. (full - 2003)
http://brain.oxfordjournals.org/cgi/...ull/126/6/1252
Non-acute (residual) neurocognitive effects of cannabis
use: A meta-analytic study (full - 2003)
http://www.hnrc.ucsd.edu/publication...348art2003.pdf
Lack of hippocampal volume change in long-term heavy cannabis users.
(abst - 2005)
http://marijuana.researchtoday.net/archive/2/4/358.htm
A preliminary DTI study showing no brain structural change associated with adolescent cannabis use (full
- 2006)
http://www.pubmedcentral.nih.gov/art...tool=pmcentrez
Effects of Alcohol and Combined Marijuana and Alcohol Use During Adolescence on Hippocampal
Volume and Asymmetry (full - 2006)
http://www.ncbi.nlm.nih.gov/pmc/arti...2/?tool=pubmed
The influence of substance use on adolescent brain development. (abst - 2009)
http://www.ncbi.nlm.nih.gov/pubmed/1...ubmed_RVDocSum